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Abstract
MICHAEL DARDEN: A Dynamic Stochastic Model of Lifetime Smoking
Behavior.
(Under the direction of Donna Gilleskie.)
This dissertation discusses results obtained through formulation and estimation of a dy-
namic stochastic model that captures individual smoking decision making, health expectations,
and longevity over the life cycle. The standard rational addiction model is augmented with a
Bayesian learning process about the health marker transition technology to evaluate the im-
portance of personalized health information in the decision to smoke cigarettes. Additionally,
the model is well positioned to assess how smoking and smoking cessation impact morbidity
and mortality outcomes while taking into consideration the potential for dynamic selection of
smoking behaviors. This research also provides a novel approach to the empirical construc-
tion of the theoretically common “smoking stock” that facilitates the estimation of investment
and depreciation parameters. The structural parameters are estimated using rich longitudinal
health and smoking data from the Framingham Heart Study: Offspring Cohort. Results sug-
gest that there exists heterogeneity across individuals in the pathways by which smoking effects
health. Furthermore, upon smoking, the estimated parameters suggest a positive reinforce-
ment effect and a negative withdrawal effect, both of which encourage future smoking. I find
that only in the case of very large change in an individual’s health markers will the associated
change in beliefs induce individuals to quit smoking. Generally, personalized health marker
information is not found to influence smoking behavior relative to chronic health shocks them-
selves. The dissertation also presents evidence of health selection in smoking behavior that,
when not modeled, may cause an overstatement of the direct effect of smoking on morbidity
and mortality.
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Chapter 1
Introduction
The decision to smoke has long interested social scientists and health policy researchers be-
cause of the seemingly irrational nature of such a choice. Why would an individual undertake
an activity with such clear negative health consequences? A thorough review of this debate
can be found in Sloan, Smith, and Taylor (2003). Ultimately, those authors conclude that
individuals make decisions within an environment that reflects individual preferences but one
that is also subject to information acquisition costs. Gary Becker describes economic decision
makers: “They (economic agents) are not expected to be perfect optimizers, as evaluated by
the analyst, or dispassionate external observers; rather, people do the best they can, given
their information and their cognitive abilities to understand it (qtd. in Sloan et al. (2003) pg.
25).” An important question addressed by the smoking literature has been: what determines
and shapes “their information?” Furthermore, how does information influence smoking be-
havior? And, to what extent has information regarding the health effects of smoking been free
from selection bias? These questions form the basis for this dissertation.
The purpose of this work is to analyze the relationship between the consumption of
cigarettes and health in a dynamic discrete choice framework that incorporates learning. I
estimate the structural parameters of an individual’s optimization problem with the follow-
ing trade-off: current enjoyment of cigarette consumption versus the associated uncertain
future utility and health consequences. I consider two dimensions of health: health markers
and chronic health. Health markers are those factors (e.g., blood pressure, cholesterol, etc.)
viewed by the medical literature to significantly predict the onset of chronic conditions (e.g.,
cardiovascular disease, cancer, etc.).1 Given a history of these health markers and smoking
behaviors, an individual is able to more precisely evaluate the effect of smoking on her health
markers levels which, in turn, helps to determine her chronic health probability. More gener-
ally, health markers offer information as to an individual’s overall health condition. Endowed
with this information, an individual makes the smoking choice that maximizes her present
discounted expected utility. Smoking history is modeled as a capital stock and is measured in
a novel way so as to facilitate the estimation of depreciation and investment coefficients while
keeping the model computationally tractable.
The structural parameters of the model are estimated with rich longitudinal data from
the offspring of the original cohort of the Framingham Heart Study. I estimate preference pa-
rameters jointly with smoking stock, health marker, chronic health, and mortality transition
parameters. Additionally, I estimate a flexible random effects specification that captures the
correlation in permanent unobserved heterogeneity across outcomes. I use a value function
interpolation method and simulated maximum likelihood to solve and estimate the model.
This dissertation fits into and extends the literature in four ways. First, the structural
model extends the standard rational addiction model of Becker and Murphy (1988) by incor-
porating both health and learning. I model individuals as forward-looking in the sense that
they evaluate current smoking alternatives while taking into consideration the future health
and utility consequences associated with past and current smoking behavior. Furthermore,
while other papers that incorporate health into the rational addiction framework (e.g., Sura-
novic et al. (1999); Carbone et al. (2005)) are purely theoretical, I estimate the preference and
expectation parameters of a rational addiction model that capture forward-looking behavior
with respect to health. Consistent with the theory of rational addiction, I find that smoking
is reinforcing in the sense that the marginal utility of smoking is increasing in the amount of
past smoking. I also find that the costs of withdrawal can prevent individuals from quitting
smoking. The reinforcement and withdrawal effects are found to drive smoking dynamics.
1See Chapter 4 for a complete list of the health markers and chronic health conditions considered.
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Second, a major contribution of this dissertation is to model how the receipt of informa-
tion about an individual’s health markers may alter an individual’s smoking behavior. When
information about the ill-health effects of smoking is made personal, the literature has argued
that this personalized health information may provide an individual with a powerful incentive
or “wake-up call” to curtail her smoking behavior (Sloan et al., 2003). As an example, if a
smoker experiences a heart attack, this health shock may be framed as an informative signal
of the consequences of her smoking.2 This dissertation extends the literature on smoking re-
sponses to personalized health information that have only considered chronic health shocks
(e.g., heart attacks, cancer diagnoses, etc.) (Smith et al., 2001; Khwaja et al., 2006; Arcidi-
acono et al., 2007). The distinction between health marker information (i.e., observing one’s
own blood pressure at a health exam) and chronic health shocks as information is important
if the potential gains from information from a chronic health shock are “too late”. Indeed,
if policy makers are concerned with improving overall expected longevity, the incidence of a
heart attack, while effective in convincing an individual to quit smoking, may not yield addi-
tional longevity. However, if changes in blood pressure, say, over time that are due to smoking,
convince an individual to quit prior to the incidence of a heart attack, then there may exist a
role for policy to emphasize the personalized “warning signs.” Thus, motivated by the Becker
quote above, my model explicitly accounts for health marker transition learning and I estimate
parameters that dictate a Bayesian learning process.
To evaluate the roles of learning and information, I use the model and the estimated
structural parameters to simulate smoking behavior and health and mortality outcomes under
different counterfactual scenarios. The results suggest that there exists heterogeneity across
individuals in the pathways by which smoking affects health. I find that the effect of an accu-
mulated smoking stock on health markers varies widely across individuals relative to the mean
effect. While the average variance in beliefs regarding this effect decreases by 20% after the
2Specifically, Sloan et al. (2003) and Khwaja et al. (2006) argue that, while general sources of health in-
formation (e.g., commercials, warning labels, etc.) may influence the light to moderate smoker, these sources
of information will have less affect on the smoking behavior of heavy smokers. Indeed, for the heavy smoker,
personalized information is required to change behavior. I will discuss the distinction between general and
personalized health information as it relates to smoking behavior in Chapter 2.
3
first health exam, the estimated mean of the parameter distribution is small and thus, does
not greatly impact smoking behavior. Counterfactuals in which individuals receive information
more and less frequently do not appear to show individuals altering their smoking behavior in
any significant sense. Indeed, only when an individual observes a discrete shock to the 90th
percentile of the health marker distribution does she begin to smoke less. While smokers are
found to quit or reduce their smoking after a chronic health shock, results from this disser-
tation suggest that health markers have limited informational value. Chapter 8 provides a
detailed description of the results from these counterfactual simulations.
Third, using data from across the life cycle, I measure the role of health and mortality tran-
sition determinants by estimating these production technologies within the structural model
of lifetime smoking decisions. This method allows both for smoking to affect health and for
rational individuals to select the optimal smoking alternative while taking into account their
health. My method improves upon recent papers that estimate health transitions outside the
structural model (Adda and Lechene, 2001). Modeling both smoking behavior and health out-
comes also allows me to capture unobserved heterogeneity that may be present in their joint
determination. For example, if smokers are also more likely to engage in other health-hazardous
behaviors (e.g. drinking, drug use, sky diving, etc.), then treating smoking as random within
the population will lead to overstated estimates of the direct effect of smoking on the health
outcome of interest. Importantly, alleviating this bias does not require the researcher to model
every potential lifestyle choice that may be correlated with both smoking and health outcomes.
Rather, to capture unobserved heterogeneity, I allow the unobserved errors that affect smok-
ing, health, and mortality to be serially correlated through a common permanent unobserved
component. I model this error structure with the discrete factor method (Heckman and Singer,
1984; Mroz, 1999) which amounts to a random effects specification of unobserved heterogeneity
that is free from distributional assumptions. The error structure is similar to recent structural
models that have accounted for unobserved heterogeneity (Arcidiacono et al., 2007; Blau and
Gilleskie, 2008).
To assess both the potential for selection on smoking and the effect of smoking on health
outcomes, I simulate the structural model under different lifetime smoking patterns. For daily
4
light and heavy smoking from age 18, individuals can expect roughly 4.5 and 8 fewer years of
longevity, respectively. These results are less severe in their overall assessment of the health
effects of smoking on mortality than are the unconditional results presented in (Doll et al.,
1994, 2004).3 My results are the first of which I am aware to explicitly control for the potential
positive selection between smoking and health outcomes while also estimating the health tran-
sition equations within the structural model of lifetime smoking. Still, consistent with some
literature on smoking and health4, my results suggest that there exist longevity gains from
quitting at any age, and that quitting prior to age 30 implies that an individual has roughly
the same expected longevity as a lifelong nonsmoker. Furthermore, I find that quitting heavy
smoking at ages 30, 40, 50, and 60 years of age increases life-expectancy by approximately 8,
7.75, 7, and 5.5 years, respectively. Interestingly, while I find that unobserved heterogeneity
plays a major role in the dynamic relationship between smoking behavior and mortality, the
unobserved heterogeneity plays almost no role in predicting health marker and chronic health
transitions. My results indicate that there exists a strong positive correlation between smoking
tendencies and underlying factors that influence mortality outcomes.5
Fourth, my model extends the empirical smoking literature with a novel construction of the
“smoking stock”. The key term in the standard rational addiction model of Becker and Mur-
phy (1988) is an addictive capital stock that is subject to investment and depreciation. Those
authors argue that addiction is captured by a positive interaction between the smoking stock
and the marginal utility of addictive consumption. While theoretically it is quite intuitive to
think an individual that has smoked in the past may have a higher marginal utility of smoking
than someone who has not smoked, it is not clear how to best capture this capital stock em-
pirically. For example, defining the stock to be the total number of years smoked ignores the
3See chapter 2 for a discussion on the medical view of smoking.
4See Doll et al. (1994); Taylor et al. (2002); Doll et al. (2004); Brønnum-Hansen et al. (2007)
5There is a large literature on the effects of smoking cessation on health outcomes. See United States
Department of Health and Human Services (1990). This issue of “smoking depreciation” is often framed as
the amount of time required after cessation until the probability of a health outcome converges to that of a
nonsmoker. Because of the generality of my treatment of health (e.g., chronic health or not), and because the
smoking cessation improves various health outcome probabilities differently, the discussion in this dissertation
focuses on the benefits from quitting smoking on expected longevity.
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importance of cessation (i.e., someone who smoked for 10 years and quit twenty years ago may
have a different marginal utility for smoking than someone who smoked for 10 years and quit
last year). Using factor analysis in a method similar to Sickles and Williams (2008), I create
a continuous smoking stock index from several variables that reflect past smoking behavior.6
This easily interpretable state variable captures the unique smoking history that each individ-
ual brings into each decision making period. Furthermore, measuring the smoking stock using
this method also allows for the estimation of depreciation and investment parameters (Adda
and Lechene, 2004).7
Finally, the structural model of this dissertation is solved and estimated using techniques
common in the structural dynamic discrete choice modeling literature (Rust, 1987; Keane and
Wolpin, 1994; Aguirregabiria and Mira, 2010). To incorporate learning, I combine several fea-
tures of other recent structural papers that have explicitly modeled and estimated Bayesian
learning processes (Ackerberg, 2003; Crawford and Shum, 2005; Chan and Hamilton, 2006;
Mira, 2007; Chernew et al., 2008). While those papers model learning about an intercept
shifting term, I model learning about a marginal effect: the effect of the accumulated smoking
stock on a set of health markers. Conditional on the unobserved heterogeneity, I use the model
to predict the initial conditions (Khwaja, 2010).
This dissertation proceeds in the following chapters. Chapter 2 provides background on
the economics and medical literatures with respect to smoking. That chapter begins with a
discussion of the ubiquitous rational addiction model, including both theoretical extensions
and alternatives and empirical applications. I also discuss the economics of information and
expectations in the context of cigarette smoking. Finally, with respect to the medical literature
on smoking, Chapter 2 places an emphasis on the effects of smoking on expected longevity.
6Sickles and Williams (2008) use principal component analysis to construct a “stock” of social capital from
several correlated variables such as labor force participation, yearly hours worked, marriage, and “hours in
income generating crime per year.” See Chapter 2 for further details.
7Adda and Lechene (2004) note that the smoking stock may be different between reinforcing further smoking
and affecting health. Indeed, those authors model two smoking stocks: a utility smoking stock and a health
smoking stock. Each are subject to different investment and depreciation parameters that are fixed. In my case,
I abstract from this possibility and estimate the transition parameters of a single stock variable that captures
past smoking.
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Chapter 3 presents the formal structural model. Chapter 4 discusses the Framingham Heart
Study and presents basic summary statistics of the data used in estimation. How the struc-
tural model in Chapter 3 and the data in Chapter 4 are reconciled is discussed in Chapter 5.
I also formally describe the econometric methods used in estimating the structural model as
well as identification issues in Chapter 5. Parameter estimates and a brief discussion of how
the estimated model fits the data are discussed in Chapter 6. In Chapter 7, I explain how
I conduct the simulations that yield the main results of this dissertation. While counterfac-
tual simulations that examine learning and information are present in Chapter 8, simulations
that assess the effect of smoking on health are presented in Chapter 9. Finally, Chapter 10
concludes. Additionally, Appendix A gives the formal derivation of posterior beliefs.
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Chapter 2
Background
Cigarette smoking is the single greatest preventable risk factor for mortality and morbidity.
Tobacco smoke contains more that 7,000 chemicals. These chemicals quickly travel from the
lungs into the blood stream, being distributed to every organ in the human body. Cigarette
smoke increases both heart rate and blood pressure because the nicotine present in tobacco
smoke activates the sympathetic nervous system (Bennett and Richardson, 1984; Omvik, 1996;
Benowitz, 2003) (USDHHS, 2010, Chap. 6, pg. 368). Furthermore, medical evidence suggests
that cigarette smoking both causes plaque to buildup in the arteries, causing an increase in
total cholesterol, as well as, a decrease in high-density lipoprotein (hdl) “good” cholesterol
(Garrison et al., 1978) (USDHHS, 2010, Chap. 6, pg. 379-380). Smoking is even considered
a risk factor for type 2 diabetes because cigarette smoke increases the degree of insulin resis-
tance. (USDHHS, 2010, Chap. 6, pg. 383).
Cigarette smoking is causally linked to cancers of the bladder, cervix, esophagus, kidney,
larynx, lung, mouth, pancreas, and stomach. Indeed, 9 out of 10 men who die from lung cancer
have a smoking history. Furthermore, there exists a causal relationship between smoking and
cardiovascular disease (both directly and indirectly through the effect of smoking on health
markers such as blood pressure), atherosclerosis, various respiratory diseases, and several re-
productive maladies. 440,000 deaths, nearly one-fifth of the annual deaths, are attributed to
smoking in the United States each year. Illness from smoking is estimated to add $157 billion
per year to national health expenditures, both from medical costs and lost productivity due
to chronic illness and premature death (USDHHS, 2010). The 2004 United States Surgeon
General report on smoking concludes by stating: “Smoking harms nearly every organ of the
body, causing many diseases and reducing the health of smokers in general.” USDHHS, 2004
2.1 The Economics of Addiction
The rational addiction framework of Becker and Murphy (1988) has been the workhorse eco-
nomic model of smoking behavior since its publication. The model is based on the premise
that smokers and nonsmokers alike know the full price of smoking. That is, smokers are mod-
eled as the forward-looking, utility maximizing agents of standard welfare economics. The key
element of this framework is an accumulated experience of smoking term that is defined as a
capital stock. By choosing to smoke in the current period, agents in the model realize that
they are investing in their stock of smoking capital. The key dynamic in this model is that,
by increasing the stock of smoking, an individual is altering the marginal utility of smoking in
future periods. When the marginal utility of consumption of a particular good is increasing
in that good’s accumulated stock, Becker and Murphy (1988) categorize the good as addictive
and exhibiting a complementary nature over time or “adjacent complementarity.” The model
is able to predict common observations such as binge behavior and “cold turkey” quitting.
Naturally, there have been numerous extensions to and deviations from the rational addic-
tion model. Orphanides and Zervos (1995) extend the rational addiction model by incorpo-
rating learning about the potential harm associated with consumption of an addictive good.
Those authors incorporate heterogeneity in the “addictiveness” of different goods and evolving
subjective assessments of this heterogeneity. By consuming a good, agents in the model learn
over time the extent to which consumption of that good causes harmful side effects; however,
the authors are agnostic as to what these side effects may be. Importantly, the model captures
that individuals with an “it won’t happen to me” attitude toward consumption of addictive
goods are precisely the individuals that may (a.) experience regret and (b.) endure the worst
effects of consumption. Alternatively, Suranovic et al. (1999) extend the rational addiction
model with a specific application to cigarette smoking that makes the withdrawal costs of
quitting explicit. In the Becker and Murphy (1988) framework, withdrawal is simply captured
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by depreciation in the addictive capital stock. Under positive adjacent complementarity, the
marginal utility of addictive consumption is lower if an agent chooses to not consume the good
in the previous period. Suranovic et al. (1999) impose adjustment costs if the agent reduces
consumption but not if she raises consumption. The model better explains why some smokers
claim to be “unhappy smokers.”
Suranovic et al. (1999) is the first paper of which I am aware that explicitly captures the
potential health consequences of smoking within a rational addiction framework, albeit in an
extremely coarse way . Indeed, in their model, agents are concerned with expected longevity.
Agents in the model understand that smoking accumulates in a capital stock that decreases
expected longevity at a fixed rate. However, those authors do not allow the smoking stock to
depreciate. Thus, the only motivation to quit smoking within their model is to prevent fur-
ther expected longevity losses. More realistically, Carbone et al. (2005) formulate a rational
addiction model that is consistent with the health production literature (Grossman, 1972). In
their model, agents select from smoking alternatives while internalizing both quality-of-life and
death risk effects. Rather than a fixed reduction in expected longevity, death is a stochastic
outcome and is a function of both current period and past smoking behavior, as well as an
overall health stock. Agents may offset the health effects of smoking with investments in other
areas of health. Those authors find that, if agents have access to medical care (i.e. forms of
health investment), then agents with a longer life expectancy are more likely to smoke early in
life because they anticipate both the depreciation of the health effects of smoking after quitting
and offsetting their smoking behavior with health investments later in life.1
In addition to numerous extensions, several alternatives to the rational addiction frame-
work have appeared in the literature. As an example of this literature, Bernheim and Rangel
(2004) propose a model in which rational economic agents are subjected to environmental cues
that may impact their ability to align their choices and preferences. The three main premises
of the Bernheim and Rangel (2004) model are: (1.) use among addicts is often a mistake, (2.)
experience sensitizes an individual to environmental cues, and (3.) addicts understand and
1This result also hinges on time-consistent preferences.
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manage their susceptibilities. Given the history an individual brings into a decision making pe-
riod, as well as some stochastic shock, an agent may depart from the standard rational state or
“code mode” and enter “hot mode”, in which consumption of an addictive good is compulsory
regardless of their contingent plan. Mistakes occur in the model when an individual rationally
chooses to abstain from consumption of an addictive good yet, due to an environmental cue
(e.g., advertisements, peers pressure, etc.), fails to follow-through with her plan. The envi-
ronmental cue distribution is a function of the environment choice (e.g., attend a party, stay
home, etc.). If the probability distribution of the environmental cues is degenerate such that
the environmental cue never exceeds the compulsory use threshold, then the model collapses
to a standard rational addiction framework. Other examples of models that deviate from ra-
tional addiction include, the time-inconsistent framework of Gruber and Koszegi (2001), in
which agents are models as present-biased decision makers, and the nonexpected utility model
of Gul and Pesendorfer (2007), in which compulsive consumption is explicitly defined as the
variation in consumption in the presence and absence of commitment devices.
Finally, given the nature of the current paper’s learning model, the issue of how to de-
fine preferences under varying degrees of uncertainty requires further discussion. The von
Neumann-Morgenstern axioms that define the expected utility framework dominate the em-
pirical smoking literature. Under this standard framework, agents are indifferent as to the
timing of the resolution of uncertainty. Furthermore, a common criticism when empirically
testing hypotheses derived from the expected utility framework has been the inverse relation-
ship between the coefficient of risk aversion and the intertemporal elasticity of substitution.
Kreps and Porteus (1978) deviate from the expected utility framework by incorporating pref-
erences over the timing of the resolution of uncertainty. A strand of theoretical and empirical
literature has flowed from Kreps and Porteus (1978). (See Kreps and Porteus (1978), Kreps
and Porteus (1979), and Epstein and Zin (1991)) In the current paper, uncertainty over the
individual specific match value is never resolved, rather just lessened (i.e., reduced posterior
variance). Implementing nonexpected utility preferences is beyond the scope of this disserta-
tion. Interesting future work might consider several preference specifications (e.g., expected
utility, Kreps Porteus preferences, hyperbolic preferences a´ la Gruber and Koszegi (2001), etc.)
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in the context of smoking and addiction.
The large empirical literature stemming from rational addiction has focused on providing
evidence of a central tenant of the theory: forward-looking behavior. Indeed, in the rational
addiction model, agents must correctly forecast the extent to which consumption of an addic-
tive good today will affect the marginal utility of consumption of that good tomorrow. Initially,
much of the empirical literature focused on price effects to provide evidence of forward-looking
behavior. Chaloupka (1991) instruments for past and future consumption of cigarettes with
past and future prices and state excise taxes and finds a positive relationship between current
and lead period smoking behavior. Becker et al. (1994) employ a similar identification strategy
as Chaloupka (1991) and find, in addition to evidence that both past and future price increases
decrease the current demand for cigarettes, that the price elasticity of demand for cigarettes
is larger in long-run than the short-run.
More in the spirit of this dissertation, Arcidiacono et al. (2007) formulate and estimate
various structural models of smoking and drinking behavior that differ on the degree to which
individuals are forward-looking. Because cigarette price effects are thought to be small for
older individuals (Sloan et al., 2003), Arcidiacono et al. (2007) model the tradeoff between
current utility from smoking versus the increased probability of future poor health outcomes
associated with smoking. Because of this intertemporal tradeoff, how individuals discount the
future will shape the “costs” of smoking. For example, a completely myopic individual in this
setting will always smoke as long as the instantaneous utility from smoking is greater than from
not smoking. In addition to a model estimated for various fixed discount rates, Arcidiacono
et al. (2007) also estimate the parameters of their model jointly with the discount factor. The
discount factor is identified by excluding age from the utility function and exploiting age vari-
ation in smoking and heavy drinking in the data. While Arcidiacono et al. (2007) are limited
by the Health and Retirement Survey to studying the smoking behavior of older individuals,
those authors show that forward-looking models better fit their data than do myopic models.
Indeed, those authors estimate an annual discount rate of 0.8192 implying a strong degree of
forward-looking behavior.
Given the focus on health effects in this dissertation, the next section is devoted to the
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literature on how individuals perceive health risks and how information and learning alter
those perceptions.
2.2 Information, Uncertainty, and Learning
Extensions of rational addiction that incorporate health effects assume that individuals base
their period smoking decisions, in part, on their assessment of the future health effects of
smoking. Therefore, one branch of the empirical rational addiction literature has studied the
roles of information, risk perceptions, subjective expectations, and learning in the decision to
smoke. Are individuals forward-looking with respect to their health and do they correctly
forecast risks associated with addictive good consumption?
Viscusi (1990) uses data on individual risk perceptions to assess whether individuals (smok-
ers and non-smokers) have accurate perceptions of the risk of lung cancer.Viscusi (1990) uses
data from a telephone survey that asked, among other questions, “Among 100 cigarette smok-
ers, how many of them do you think will get lung cancer because they smoke?” Viscusi
compares the response rate from the telephone surveys to risk assessments constructed from
the United States Department of Health and Human Services data on the number of lung
cancer deaths per year. The results show that both smokers and nonsmokers overestimate the
risk of lung cancer associated with smoking. Indeed, if individuals are concerned with avoiding
lung cancer, the overstatement of the risk associated with smoking may cause individuals to
smoke less if the risk were correctly perceived. Viscusi argues that lung cancer risk perceptions
increasing excise taxes on cigarettes has a very similar effect on smoking behavior as increasing
lung cancer risk perceptions. These results are confirmed and updated in Viscusi and Hakes
(2008).
Of course, assessing the extent to which individuals correctly predict the health conse-
quences of smoking requires that the baseline objective consequences themselves are correct.
The researcher cannot assess the accuracy of risk perceptions if the “established” risk itself is
biased. In Viscusi (1990), the accuracy of the official risk assessments is not questioned. If,
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for example, the effect of smoking on expected longevity is confounded by dynamic selection
with respect to smoking, then the loss of longevity estimate will be biased. I will review the
literature on expected longevity loss from smoking in the next section.
Furthermore, another criticism of the Viscusi (1990) approach is that the survey ques-
tions ask respondents only about the generic smoker and not the individual in question. If
individuals have a “it won’t happen to me” attitude about health risks, then subjective ex-
pectations elicited about the general population risk may be more severe than the individual
specific subjective expectations. This distinction is important because when the a rational,
forward-looking individual makes the current period consumption decision, she does so based
on her subjective assessment of her own risk. Importantly however, these studies do show that
individuals are forward-looking and not myopic with respect to the health consequences of
smoking decisions. Furthermore, these studies establish that information can change behavior
by altering risk perceptions.
Viscusi (1990) also makes a theoretical contribution by modeling an individual’s beliefs re-
garding her health risk from cigarette smoking as a Bayesian function of three factors: a prior
risk assessment, some measure of risk from experience (perhaps smoking history, age, etc.),
and some new information regarding risk. An important question addressed by the literature
has been: what exactly is this new risk information?
One type of new information can be categorized as any information that is directed toward
a general audience. A widely publicized example was the landmark 1964 United States Surgeon
General report that linked smoking to lung cancer and certain birth defects. Luther L. Terry,
then Surgeon General, stated that the report “hit the country like a bombshell. It was front
page news and a lead story on every radio and television station in the United States.”2 Did
this information deter individuals from taking up smoking? Did smokers at the time respond
to the report by quitting? On this question, the literature has been mixed. While much of
the literature suggests that informational anti-smoking campaigns decrease cigarette demand
for light to moderate smokers, Sloan et al. (2003) argue that heavy smokers “do not appear to
2http://profiles.nlm.nih.gov/NN/Views/Exhibit/narrative/smoking.html
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update these perceptions (on the probability of illness/death due to smoking) in response to
general information; they need the message to be personalized.”3
Personalized health information may be an important motivator to quit if heavy smok-
ers possess an “it won’t happen to me” attitude. Khwaja et al. (2006), studying individuals
from the Health and Retirement Survey (HRS), show that smokers “learn” about the risks
associated with smoking, as measured by a change in smoking behavior, only from a shock
to their own health. Wray et al. (1998) find a similar result and note that, following a heart
attack, there is a strong positive relationship between the propensity to quit and education.
Khwaja et al. (2006) argue that if any health shock other than one’s own would encourage
smoking cessation, it should be that of a spouse. The authors however find no significant effect
of spousal health shocks on smoking behavior. Sloan et al. (2003) conclude that “the clear
differences in the effects of smoking-related health shocks for current smokers suggest that
personalized messages, relevant to their circumstances, are necessary to get their attention
and induce changes in their beliefs (qtd. in Sloan et al. (2003) pg. 124).”
Nearly all previous work that has examined learning or expectation formation with respect
to personalized health messages has studied behavioral changes after a major health shock to
self or spouse (Smith et al., 2001; Khwaja et al., 2006; Arcidiacono et al., 2007). Addition-
ally, most papers focus on individuals above the age of 50, at which age we begin to observe
the major health implications of smoking. For example, using Health and Retirement Survey
data, Smith et al. (2001) show that current smokers update their subjective longevity ex-
pectations given a chronic, smoking-related health shock (e.g., certain cancers, cardiovascular
disease, etc.) differently than do former and non-smokers. Those authors find no difference
in longevity updating for health shocks that are unrelated to smoking (e.g., prostate cancer).
Their study concludes, “it remains to be evaluated whether messages can be designed that
focus on the link between smoking and health outcomes in ways that will have comparable
effects (to chronic health shocks) on smokers’ risk perceptions.”
3Italics theirs.
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This dissertation explores the notion that personalized health information does not neces-
sarily have to come in the form of a major health shock after age 50. Indeed, as recognized by
the literature, waiting for a major health shock to incite individuals to quit smoking may be
too late in terms of life expectancy gains. Therefore, one goal of this dissertation is to examine
the extent to which personalized health marker measures (e.g., blood pressure, cholesterol,
etc.) at all ages might inform individuals of the health risks associated with smoking. As
shown above, the medical literature suggests that a number of health markers that predict
many chronic health outcomes may be influenced by smoking cigarettes. Health markers are
theorized to provide tangible evidence to both the “it won’t happen to me” and the light
smoker of the health risks associated with smoking without being a one-off, potentially fatal,
signal of information. For example, the Surgeon General now recommends that physicians
point out to patients the fact that smoking raises blood pressure.4 To my knowledge, no study
has examined the impact of personalized health marker information on the decision to smoke.
The extent to which information on these health markers may affect the decision to smoke are
central questions of this research .
2.3 Smoking, Health, and Selection
Behind much of the United States Surgeon General Report’s results is the work of (Doll et al.,
1994, 2004). Those authors use survey data of British physicians over several decades to assess
the impact of cigarette smoking on mortality. For different birth cohorts, those authors con-
struct the relative risk of death, defined as the age specific mortality for a group in question
relative to some baseline group. Their findings suggest that smoking cessation at ages 30, 40,
50, and 60 leads to improved life expectancies of 10, 9, 6, and 3 years respectively. Further-
more, life-long smokers face a roughly 25 percentage point increase in the probability of death
during middle aged (35-69). They conclude that, for men born between 1900 and 1930 who
smoked only cigarettes, the mean reduction in longevity was ten years relative to a group of
life long nonsmokers. However, those authors do not consider the intensity with which one
4http://www.cdc.gov/tobacco/data statistics/sgr/2010/clinician sheet/pdfs/clinician.pdf
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smokes in any of their reported results. As I show in this dissertation, the intensity with which
one smokes greatly influences the potential loss of longevity.
Taylor et al. (2002) use data from the Cancer Prevention Study II to assess the life-years
lost from smoking and the longevity benefits of smoking cessation at various ages. They esti-
mate the relative risk of mortality for different categories of smokers. Unfortunately, after an
initial interview in 1982, longitudinal data is only available for a self-selected fraction of the
baseline sample. After attempting to correct for misclassification of mortality due to changes
in smoking behavior over the study period, the authors find that men that never smoke have
an mean expected longevity that is 8.9 to 10.5 years longer than those that smoke until death.
For women the life extension is 7.4 to 8.9 years. Furthermore, Taylor et al. (2002) find that
there are expected longevity gains from smoking cessation at all ages. For example, individuals
that smoke until age 65 and then quit, gain about 1 and 2.7 year(s) of life expectancy for men
and women respectively.
Employing a similar relative risk methodology to Doll et al. (2004), Brønnum-Hansen et al.
(2007), using mortality data from Danish Health Interview Survey find that expected longevity
from age 25 is reduced by 8.7 years for men and 10.4 years for women for heavy smokers (≥ 15
cigarettes/day) relative to life long nonsmokers. Additionally, those authors find that heavy
smokers had 10.5 fewer years without chronic “limiting” illnesses relative to life long nonsmok-
ers. Taking into account secondary factors, Jha et al. (2006) focus on smoking attributed
mortality differences by overall socioeconomic status. They find that more than half of the
absolute difference in mortality rates can be attributed to smoking-related health problems
and that smoking contributed to over 40% of middle-aged deaths (35-69) for the lowest socioe-
conomic group.
In assessing the effect of smoking cigarettes on expected longevity, an important consid-
eration is the extent to which selection and endogeneity play roles. For example, each of the
above studies ignores the potential correlation between preferences for smoking cigarettes and
the mortality outcomes in question. Perhaps, individuals that are more likely to enjoy smoking
(e.g., because of parental effects, stress, environmental cues, etc.) are also more likely to die
for other reasons independently of smoking (e.g., alcohol and other drug consumption, risky
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lifestyle behaviors, etc.). In effect, these studies are treating smoking as a random event, in
direct odds with the rational addiction framework above. Furthermore, these studies ignore
the possibility of health selection in smoking behavior. If, independently of smoking, smokers
are of a worse overall health status than non-smokers, standard statistical methods may over-
state the effect of smoking on mortality. Indeed, only recently have papers in health economics
begun to jointly model smoking and health outcomes. For example, Adda and Lechene (2001)
show that potential life-span and smoking behavior are correlated along unobserved (to the
econometrician) dimensions. However, Adda and Lechene (2001) estimate survival probabili-
ties independently of smoking and fix key depreciation parameters. Adda and Lechene (2004)
try to control for the selection problem by constructing a health index that proxies for the
health of a smoker had the individual not smoked. Those authors are not able test whether
cigarette smoking changes in behavior over time influence their health index because they have
a very short panel.
2.4 Empirical Methods
One contribution of this dissertation is the empirical treatment of the theoretically common
“smoking stock.” In the rational addiction framework, an individual’s smoking stock is a con-
tinuous, scalar representation of all past smoking behavior. Becker and Murphy (1988) specify
this history as a capital stock that is subject to depreciation and withdrawal. To test a central
tenant of the rational addiction theory, the stock must be constructed such that it captures
how all past consumption (smoking) influences the marginal utility of current consumption.5
One candidate for the smoking stock state variable is simply the number of years smoked in the
past. For example, consider a longitudinal dataset that includes whether an individual smoked
and the intensity with which he/she smoked in each period. A simple stock specification could
simply be the total number of past periods in which an individual smoked. However, this
5For the purposes of this discussion, I will use smoking as the running example. As noted in Becker and
Murphy (1988), a wide variety of goods can be considered addictive and this discussion applies to these goods
as well.
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specification ignores the possibility that the timing of when an individual smoked is important
in predicting current smoking through the marginal utility. That is, two individuals may have
each smoked for 10 periods, but one individual smoked more recently than the other. Fur-
thermore, this specification ignores important information with respect to the intensity with
which someone smokes (i.e., one cigarette per day versus one pack of cigarettes per day).
To capture both duration and timing, as well as intensity of smoking, I use a data reduc-
tion method, principal component analysis (PCA), to construct the stock variable. Clearly, in
the context of structural models, reducing the dimension of the state space is advantageous.
However, Sickles and Williams (2008) is the only paper of which I am aware that uses a data
reduction method to construct a state variable in a dynamic structural model. In their ap-
plication, overall individual capital is decomposed into a standard human capital stock and a
“social” capital stock. Both capital stocks are then used to help explain observed patterns of
criminal behavior at both the extensive and intensive margins. The social capital stock is con-
structed from past criminal behavior, labor force variables, and demographic characteristics
to account for the social norms that may influence crime related decisions. Importantly, and
similarly to this dissertation, those authors are able to use data to construct a theoretically
well defined term: social capital.
Before proceeding, I present a overview of principal component analysis and a brief ex-
ample. Consider a dataset with k variables and n observations. In matrix notation, denote
Xn×k as these data. The total variation in the data can be summarized via the product X ′X,
which is a square k×k matrix. Given the k dimensions and the fact that the matrix is square,
we can (normally) derive k eigenvectors of the matrix. Each eigenvector explains an orthog-
onal part of the total variation in X ′X. Associated with each eigenvector is an eigenvalue
that scales the eigenvector. Because the sum of the k eigenvalues equals k, each eigenvalue
represents the proportion of variance explained by its corresponding eigenvector. Sorting the
eigenvectors by the corresponding eigenvalues from largest to smallest ranks the eigenvectors
by the amount of total variation explained in X ′X. The key attribute is that the eigenvectors
are orthogonal. Thus, each eigenvector explains a different part of the total variation in X ′X.
The first principal component is constructed as a linear combination of the k variables and
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the associated factor loadings from the eigenvector with the highest eigenvalue. PCA is a
non-parametric method that restricts the squared eigenvector components to sum to one. As
an example, suppose a researcher wants to construct a wealth index. The available data have
40 variables that are loosely related to wealth. The researcher may employ PCA to reduce the
dimension of this information. Suppose the first 3 principal components explain 95% of the
total variation in the 40 variables. The researcher could use the first three PCs in his analysis
without losing much information and while greatly simplifying the computational burden of
the analysis. Of course, choosing the number of principal components to use is more art than
science. I postpone the discussion of my specific smoking stock treatment until Chapter 5.
Finally, in this dissertation, estimation of the primitive parameters of one’s decision making
optimization problem (e.g., preferences, constraints, and expectation parameters) allows me
to assess the impact of smoking on morbidity and mortality outcomes while considering the
potential for endogeneity of and dynamic selection into smoking behaviors. In addition, the
introduction of serially correlated (permanent) unobserved heterogeneity that affects decision
making over the life cycle (including observed initial conditions) allows for the recovery of pa-
rameters that measure the impact of smoking and health markers on morbidity and mortality
that are free of selection bias. Unbiased estimation of these primitive parameters allows me
to simulate the model and impose different patterns of smoking and quitting to examine the
resulting changes in predicted health outcomes. Finally, my model builds on the Bayesian
learning structural models of other papers in pharmaceutical demand (Crawford and Shum,
2005; Chan and Hamilton, 2006), fertility and infant mortality (Mira, 2007), marketing (Acker-
berg, 2003), and health plan report cards (Chernew et al., 2008). I postpone a thorough review
of my solution and estimation methods until Chapters 3 and 5, respectively.
20
Chapter 3
Theoretical Model
This chapter describes both the main theoretical model of the dissertation and the solution
methods used to solve the model. When necessary, I discuss the econometric structure that
facilitates estimation within this section; however, I postpone the comprehensive discussion of
my specific estimator, simulated maximum likelihood, to chapter 5. Furthermore, changes to
the model that are required due to data limitations are discussed in chapter 5.
I specify a dynamic stochastic model of smoking behavior that incorporates learning. Con-
sider a mixed discrete/continuous-state, discrete-time model in which a the time subscript t
corresponds to individual i’s age . The relevant time frame is from age seven until death. The
model has a finite horizon in the sense that, while I model an explicit stochastic probability
that an individual may die prior to period T , the probability of death equals one in period T .1
Let a representative period t follow the following time line.
Knowledge
t
of Past
Behavior and
Health
Health
Exam
Updating
Smoking
Decision
Health
Events
t+ 1
1T is set to age 100. Finite horizon models are common in the dynamic discrete choice structural model
literature because iterating on the value function is computationally burdensome. See (Rust and Phelan, 1997;
Aguirregabiria and Mira, 2010) for a discussion.
An individual enter the period with knowledge of her past smoking behavior and their past
health. Next, an individual undergoes a health exam in which she learns some personalized
information about a set of her health markers. Using the health marker information, an indi-
vidual then updates her beliefs on how her smoking behavior has affected her health markers.
Conditional on her updated beliefs and other state variables, the individual then makes her
period t smoking decision. Finally, if any chronic health or mortality events occur, they are
assumed to take place at the end of the period. In the following sections, I describe each of
these points in greater detail.
3.1 Knowledge Entering the Period
Following the rational addiction literature, Ait represents the accumulated smoking “stock”.
The concept of a smoking stock is not immediately intuitive. Broadly speaking, the rational
addiction literature treats the stock as a measure of past smoking. Medically, however, we
might consider the stock as some accumulation of tar in the lungs that influences health.
Alternatively, we might think of the stock as a measure of dependence on nicotine. These
alternative definitions are suppressed in the current model in favor of a stock variable that
may be interpreted as a continuous summary of an individual’s smoking history. Here, the
extent to which Ait influences health and future smoking probabilities is dependent on the
model parameters, and thus an empirical question. Formally, the stock is defined as:
Ait =
 exp
{
δ1ln(Ait−1) + δ21[dit−1 = 1] + δ31[dit−1 = 2] + ρAµi + ηit
}
if
∑t−1
n=1 din > 0
0 otherwise

(3.1)
Equation 1 says that individual i’s time t smoking stock is normalized to 0 if she has not
smoked in any previous period. Conditional on any past smoking, the stock is specified as a
function of the previous period stock and the previous period decision, to be defined below.
δ1 can be interpreted as one minus the depreciation rate of the stock in percentage terms.
The nonlinear investment of light and heavy smoking into the smoking stock are captured
by δ2 and δ3, respectively. Unobserved and individual specific permanent heterogeneity is
22
captured by the µi term and its factor loading ρ
A.2 Also influencing the stock is an i.i.d.
white noise term, ηit, which is distributed N (0, ση).3 Consistent with the interpretation of the
stock as a summary of an individual’s smoking history, the stock is assumed to be known by
the individual in each period.
Also known to the individual at the beginning of period t is her overall chronic health state,
Hit. Let Hit = h, where outcome h is as follows:
h =
 1 if Chronic Condition0 if No Chronic Condition

While I postpone a more complete definition of possible chronic conditions to chapter 4, the
chronic health state can be thought of including all types of cancers and forms of cardiovascular
disease. For the purposes of the theoretical model, a chronic condition captures some of the
potential consequences of smoking. As I show below, smoking influences the probability of
contracting a chronic condition which, in addition to smoking, affects the probability of death.
Furthermore, as will be seen in the utility function, preferences for smoking may vary depending
upon an individual’s chronic health state. While aggregating the data into a dichotomous
indicator for chronic is a coarse treatment of health, this method allows for chronic health to
affect other probabilities and preferences within the model in a computationally tractable way.
Furthermore, the chronic health state need not be interpreted as the set of diseases caused by
smoking. Rather, individuals in the model understand that smoking cigarettes simply raises
the probability of transiting to the chronic health state. This interpretation is consistent with
the treatment of health in Arcidiacono et al. (2007), where “bad health” is simply the absence
of self-reported “good health”.
2See section 5 for a discussion of estimation and interpretation issues regarding the permanent unobserved
heterogeneity.
3Given the exponential stock evolution equation, η is a log normal shock.
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3.2 The Health Exam
Next, an individual attends a health exam and receives personalized health information about
health markers (e.g., blood pressure, cholesterol, etc.). Define Rit as a continuous scalar
summary of these health markers. Rit is assumed to evolve as follows:
Rit = ζRit−1 +Xitφ+ κit + ρRµi. (3.2)
Here, Xit is a vector of sociodemographic characteristics of individual i. I assume that the
technology associated with these characteristics (i.e., φ) is known by the individual. ζ captures
the dynamic aspect of the health markers and is also assumed to be known to the individual.
Time invariant and unobserved (to the econometrician) heterogeneity is captured by the µi
term and its factor loading ρR. Let κit represent the input from the smoking stock plus an
idiosyncratic, i.i.d. error term that is defined as:
κit = θiAit + νit. (3.3)
Because the individual observes or knows Rit, ζ, Xitφ, and ρ
Rµi, κit is also observed by the
individual. I allow there to be heterogeneity in the effect of the accumulated smoking stock,
Ait, on the summary measure of health markers, Rit. I theorize that each individual is endowed
with a time invariant, unknown (to both the individual and econometrician) match value θi
that captures this idiosyncratic relationship. θi is drawn from a known population distribution
given by:
θi ∼ N (θ, σ2θ).
κit therefore serves as a noisy signal of information. Over time, by having health exams and
thus observing a sequence of signals, θi is learned in a Bayesian fashion. Learning is, however,
confounded by the i.i.d. noise term, νit. Indeed, without νit, an individual would perfectly
learn their match value θi at the first health exam (i.e., the first realization of κit). While νit
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is unknown, its distribution is known and given by:
νit ∼ N (0, σ2ν).
Because θi is time invariant, and because the distributions of θi and νit, as well as the stock
Ait, are known, over time, an individual can learn her idiosyncratic value of θi.
4
3.3 Learning
Let an individual’s period t posterior beliefs, those with which she forecasts future health
markers, be given by τit, her posterior mean, and ψit, her posterior variance. I assume rational
expectations such that an individual’s initial belief, prior to any health exams, regarding
her true θi (the marginal effect of one’s smoking history, Ait, on health markers, Rit) is the
population distribution.5 Initial beliefs (t = 0) are:
τi0 = E0(θi) = θ
ψi0 = V0(θi) = σ
2
θ .
Expectations about future health marker transitions evolve in the current model with the
receipt of personalized health information. In deriving posterior beliefs, consider an individual
in period t with smoking stock Ait. This individual has two fundamental sources of information:
her prior beliefs, (τit−1, ψit−1), and the observed results from her period t health exam, κit.
Appealing to the assumption of conjugate prior and signal distributions, the period t beliefs
have closed form solutions that are given via Bayes’ Rule. The posterior mean and variance
4The assumption that an individual knows the technology of the health production function is ubiquitous in
health economics. That is, typically θi = θ ∀ i and σθ = 0. θ is then estimated and assumed to be the marginal
product that all individuals use to solve optimization problems.
5The rational expectations assumption is what is typically made in most models of health transitions.
25
are :6
τit = E(θi|κit, Ait, τit−1, ψit−1) = A
2
itψit
σ2ν
θˆit +
ψit
ψit−1
τit−1 (3.4)
ψit = V ar(θi|Ait, ψit−1, σν) = ψit−1σ
2
ν
A2itψit−1 + σ2ν
. (3.5)
Here, θˆit is the least squares estimate of κit on Ait from the within individual variation of the
tth health exam. Note that these beliefs have the following appealing properties. First, the
posterior mean is a weighted average of θˆit and the original prior mean τit−1. Second, the
weight placed on the period t signal (i.e., θˆit) is increasing in the smoking stock. Finally, the
posterior moments of an individual for whom the stock equals zero (i.e., Ait = 0) collapse to
the prior moments.
3.4 The Smoking Decision
Each period, a forward-looking individual makes a smoking decision to maximize her lifetime
discounted expected utility. Let the decision for individual i be given by dit = d, where smoking
alternative d is:7
d =

0 Do not smoke
1 Smoke ≤ 1 Pack/day
2 Smoke > 1 Pack/day

The set of factors that influence individual i′s smoking decision in period t are given by the
state space Sit. Define Sit as follows:
Sit = {Ait, Rit, τit, ψit, Hit, Xit}
where Ait is individual i
′s smoking stock entering period t; Rit is her health marker index; τit
and ψit are her mean and variance respectively of her posterior belief distribution; Hit is her
6Derivations of these equations can be found in Appendix A.
7Aggregating the smoking decision to this level is a simplifying assumption. However, the model is still able
the important distinction between light and heavy smoking that is often ignored in the medical literature.
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chronic health status; and Xit is her set of demographic characteristics. Additionally influenc-
ing behavior, but not listed here, are a preference error it and a permanent heterogeneity term
µi that are both assumed to be known to the individual but unobserved to the econometrician.
Following the standard expected utility framework, an individual makes the smoking deci-
sion by evaluating the lifetime present discounted expected value of each smoking alternative
and selecting the highest valued alternative. The deterministic portion of per-period utility
associated with health state h, (h = 0, 1) and smoking alternative dit = d is:
U
h
(Sit, dit = d, µi) =
α0h
+(α1h + α2hAit + α3hRit + α4hAgeit) ∗ 1[dit = 1]
+(α5h + α6hAit + α7hRit + α8hAgeit) ∗ 1[dit = 2]
+α9h ∗ 1[dit−1 6= 0] ∗ 1[dit = 0]
+α10hAit + α11hA
2
it
+ρUhdµi
(3.6)
First, note that all utility parameters are chronic health state specific and the value of death
is normalized to zero. Because there is no explicit outside consumption good, the utility
framework focuses on how smoking and health shift utility from some baseline levels, α0·.
The specification accommodates any nonlinearity in the effects of light and heavy smoking on
utility. While α1· (α5·) is the direct marginal utility of light (heavy) smoking, α2· (α6·) captures
the extent to which past consumption reinforces current consumption. α2· (α6·) captures a part
of the intertemporal trade-off in utilities. The extent to which the health marker index affects
the marginal utility of smoking is captured by α3· (α7·). Note that higher values of Rit and
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Ait imply worse health and a higher smoking stock respectively. The signs and magnitudes of
α2· α3·, α6·, and α7· are empirical questions. α4· (α8·) captures changes in the marginal utility
of smoking across the lifespan. Specific withdrawal costs from quitting, which also capture
part of the intertemporal utility trade-off, are captured by α9·. Finally, α10· and α11· capture
tolerance in smoking. That is, the extent to which a given level of stock affects utility is
captured here regardless of smoking behavior.
Relative preferences over smoking alternatives hinge on two main factors. First, preferences
vary by the chronic health state (Hit = h). The extent to which the marginal utility of smoking
varies across chronic health states remains an open question. Generally, the marginal utility
of consumption of any normal good is thought to be lower in worse health states (Viscusi
and Evans, 1990; Gilleskie, 1998). If however smoking provides relaxation and comfort when
stricken with a chronic illness, the overall marginal utility of smoking may be larger in worse
health states. Estimation of the structural parameters will therefore empirically test for the
sign of the marginal utility of smoking across health states. Second, as seen in equations for
the smoking stock and health marker index, current period smoking affects the size of the
next period smoking stock, which in turn affects the next period health marker index and
next period utility. Given the dynamic nature of the model, individuals evaluate smoking
alternatives while considering the future marginal utility of smoking as well as the future
consequences of a higher Ait.
Following Rust (1987), let the total current period utility be the sum of the deterministic
utility from equation 3.6 and an additive i.i.d. preference shock that is alternative and health-
state specific:
Uh(Sit, dit = d, µi, 
dh
it ) = U
h
(Sit, dit = d, µi) + 
dh
it .
In the empirical implementation below, dhit is simply an additive econometric error; however,
in the theoretical model, dhit is given a structural interpretation as an unobserved state variable
(Aguirregabiria and Mira, 2010). The alternative specific lifetime value function, conditional
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on unobserved heterogeneity µi, is:
V hd (Sit, 
dh
it |µi) = Uh(Sit, dit = d, µi) + dhit + β
[
(1− ςt+1)
1∑
a=0
piat+1Et[V
a(Sit+1|µi)|dit = d]
]
.
(3.7)
Here, the value function, V a(Sit+1|µi), is the maximal lifetime utility in period t+ 1 of being
in chronic health state a. The explicit probabilities ςt+1 and pi
a
t+1 that alter the future value
function are the probabilities of death and chronic health state a respectfully and are defined
below. The value function is conditional on the unobserved heterogeneity component µi.
The expectation operator is taken over the distribution of the individual match value θi, the
smoking stock and health marker state variables, and the preference error . To evaluate this
integral, I proceed in two steps.8 First, let V
h
(Sit|µi) =
∫
V h(Sit|µi)dG(dhit ), where G(dhit )
is the cumulative distribution function of . By assuming that dhit is i.i.d. Extreme Value Type
I distributed, the maximal (EMAX function) expected lifetime utility has the following closed
form solution:
V
h
(Sit+1|µi) = EC + ln
(∑D
d=1 exp
(
V
h
d(Sit+1|µi)
)) ∀t, ∀h. (3.8)
Here, EC is Euler’s constant. However, I still must integrate over future state transitions and
beliefs. Thus, in the second step, given the unitary dimension of the posterior distribution, as
well as the i.i.d. nature of other shocks in the model (smoking stock and health marker error
terms), I use a Monte Carlo method to evaluate the expectation within solution to the model
(described below). Finally, if we assume the error term dt is additively separable, then we can
decompose the choice-specific value function to be V
h
d(Sit|µi) = V hd (Sit, dhit |µi) − dhit and the
conditional choice probabilities take the following dynamic multinomial logit form:
p(dit = d|Sit, µi) =
exp
(
V
h
d(Sit|µi)
)∑2
d=0 exp
(
V
h
d(Sit|µi)
) ∀t, h (3.9)
8This procedure is possible because the preference error  is i.i.d. across choices, health states, and time and
enters the utility function additively.
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To preview the empirical implementation, the conditional smoking choice probability in equa-
tion 3.9 enters the likelihood function. The parameters that dictate the choice probability are
structural in the sense that they are follow from the above maximization problem.
3.5 Chronic Health and Mortality
At the end of the period, with some probability an individual may transit to the chronic health
state. What differentiates Hit and Rit is “reversibility”. While Rit changes each period, I
assume that upon diagnosis of a chronic condition, an individual has the condition forever.9
Let the probabilities of transiting to different chronic health states in period t+ 1 be:
pi0t+1 =
 [1− P (Ht+1 = 1|Sit, dit, µi)] if Hit = 00 if Hit = 1

pi1t+1 =
 P (Ht+1 = 1|Sit, dit, µi) if Hit = 01 if Hit = 1
 .
Define the relevant probability, P (Ht+1 = 1|Sit, dit, µi), with the following binary logit equa-
tion:
exp(λ0+λ1Rit+λ2R
2
it+λ31[1980s]∗Rit+λ41[1990s]∗Rit+[λ5+λ6Rit]∗dit+λ7Xit+ρHµi)
1+exp(λ0+λ1Rit+λ2R
2
it+λ31[1980s]∗Rit+λ41[1990s]∗Rit+[λ5+λ6Rit]∗dit+λ7Xit+ρHµi)
(3.10)
Here, Rit is the health marker index defined above, Xit is a vector of exogenous individual
characteristics, dit is the smoking choice and µi is an individual, time invariant unobserved
heterogeneity term. The factor loading superscript H simply differentiates it from other factor
loadings in the model. λ6 and λ7 capture changes over time in how health markers affect
the probability of chronic disease incidence (perhaps due to advances in medical technology,
pharmaceuticals, etc.).
In forecasting future chronic health transitions, I follow the literature and assume that an
9This assumption captures the fact that upon having an heart attack, for example, an individual is in a
fundamentally different health state even if they don’t have repeated heart attacks (Khwaja et al., 2006).
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individual has rational expectations and that she understands the technology associated with
the chronic health transition probability. A natural question becomes, why do individuals in
the model learn about how smoking affects health markers but not chronic conditions? By
modeling learning about the effect of Ait on Rit, however, individuals are indirectly updating
their expectations about future chronic health transitions because the health marker index
enters the chronic health transition probability. Furthermore, the purpose of this paper is to
explore the importance of health information prior to major health shocks. Imposing that
individuals understand the technology (i.e., the λs) associated with covariates in the chronic
health transition equation is the standard approach. While future work may incorporate
learning about health transition probabilities, such learning is currently beyond the scope of
this paper.
Finally, conditional upon her period t smoking decision, her realized chronic health state,
Hit+1, and other state variables, Sit, an individual may die at the end of period t. Define
an indicator for death at the end of period t, Mit+1=1, and let its corresponding probability,
ςt+1 = P (Mit+1 = 1|Sit, dit, µi), be given by:
exp(ω0+ω1Rit+ω2R
2
it+ω3Hit+1+[ω4+ω5Rit+ω6Hit+1]∗dit+ω71[1980s]∗Hit+1+ω81[1990s]∗Hit+1+ω9Xit+ρMµi)
1+exp(ω0+ω1Rit+ω2R
2
it+ω3Hit+1+[ω4+ω5Rit+ω6Hit+1]∗dit+ω71[1980s]∗Hit+1+ω81[1990s]∗Hit+1+ω9Xit+ρMµi)
(3.11)
Here, Hit+1, is individual i
′s chronic health state at the end of period t.10 Again, the super-
script on the factor loading simply differentiates it from other factor loadings. The technology
for the death transition equation is assumed to be known by the individual. ω7 and ω8 capture
the fact that, conditional on having some chronic illness, the probability of death from that
illness may have changed over time due to medical advances. Furthering the discussion above,
because the health marker index enters the death transition equation directly (and indirectly
through the chronic health term Hit), individuals are indirectly updating their expectations
10The timing convention here is due to data aggregation. Clearly, any chronic health event occurring in period
t must occur at or before the time of death, if death also occurs in t. Therefore, to accommodate the frequent
observation in the data of an individual dying from a chronic health event, the appropriate chronic health data
point in this equation is Hit+1.
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about death transitions conditional on their smoking choice through the learning process. As-
suming that the ωs are known by the individuals is the standard approach and one that can
be relaxed in future work.
After the realization of the chronic health and mortality outcomes, conditional on remain-
ing alive, time transitions to period t + 1. The decision making process is consistent in the
sense that, conditional on an individual’s state, the problem to be solved is the same across
time. Furthermore, the fixed discount factor rules out any time inconsistency with respect to
preferences. Solution of the model amounts to characterizing the integrated Bellman equa-
tion (EMAX) in equation 3.8. I will discuss the solution and estimation method together in
Chapter 5.
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Chapter 4
Description of The Framingham Heart
Study
The Framingham Heart Study is one of the longest running panel studies in the world. With
the stated goal to “identify the common factors that contribute to cardiovascular disease”, the
Study contains repeated observations of individuals over a 50 year period.1 Research mile-
stones from the Study range from the causal relationship between cigarette smoking and heart
disease in the early 1960s to the effect of obesity on heart failure and the lifetime risks of
contract various cardiovascular ailments. Indeed, the Study has resulted in over 1200 scholarly
articles being published in medical journals.
Beginning in 1948, the Framingham Heart Study began collecting biennial health data
from 5,209 individuals living in Framingham, Massachusetts. These individuals formed what
became known as the Original Cohort. Participants underwent physical examinations as well
as lifestyle interviews. While the nature of these examinations has changed dramatically over
the study period, there has been a constant focus on cardiovascular health. In 1971, the
Framingham Heart Study began following the offspring and spouses of the Original Cohort to
form the Offspring Cohort. Each cohort, the Original and the Offspring, represents a differ-
ent panel study that has continued into the 21st century. While lacking income information
and geographical variation, the data contain a wealth of health and smoking information that
1The Framingham Heart Survey: http://www.framinghamheartstudy.org/index.html
are ideal for analyzing the tradeoff between smoking and the potential for future health shocks.
4.1 Sample Construction
The structural model in chapter 3 is estimated with data from the Framingham Offspring
Cohort.2 The decision to focus on data from the Offspring Cohort stems from the consistency
with which the health exams were administered. Smoking and health questions changed sub-
stantially over time in the Original Cohort; thus, constructing uniform measures of smoking
history, per-period behavior, and health variables (especially health markers) proved to be
difficult. In constructing the sample used in estimation, I drop all individuals with a miss-
ing exam and all those lost to attrition. Those with missing exams were dropped because,
given the length of time between exams, assessing smoking behavior during the interim period
proved to be difficult. An additional 671 individuals are lost to attrition (i.e., some reason
other than death) at some point during the seven exams. Those that attrit from the sample
constitute approximately 18% of the sample. The decision to drop these individuals is based
on the computational tractability of modeling attrition. Simple t-tests for difference of means
suggest that those that attrit are slightly more likely to be women, have a three point lower
level of systolic blood pressure on average, and have a statistically insignificant difference in
coronary heart disease incidence than their nonattriting counterparts. Those that attrit are
on average slightly more likely to smoke. Thus, due to the restrictions I have placed on the
sample, the only reason individuals leave the sample is through death. As shown in Chapter
3, the probability of death is explicitly modeled.
Table 4.1 explains my process of sample construction. The full sample contains 5,124 in-
dividuals. For this work, I only have access to data for those individuals from whom consent
for distribution was granted. The final sample consists of 19,461 person/year observations.
2In another study, I am examining the intergenerational transfer of smoking preferences between Original
and Offspring Cohort participants.
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Table 4.1: Sample Construction
N Description
4989 Framingham Heart Survey Offspring Cohort Participants - Restricted Sample
3730 Sample after dropping those individuals that skipped one or more of the health exams
3008 Sample after dropping all person/year observations of individuals who attrit
3008 unique individuals yields 19461 person/year observations.
Source: The Framingham Heart Study, Offspring Cohort.
4.2 Sample Statistics
The sample statistics given in this section are by Framingham Heart Study exam. I postpone
the reconciliation of the data and the theoretical model to chapter 5. I have data for each
individual in the Framingham Heart Survey Offspring Cohort for up to seven health exams.
Initial health exams were conducted between 1971 and 1975. For each participant, subsequent
exams occurred at varying time intervals. Table 4.2 provides information on the average timing
of each exam across individuals, in addition to demographic information. Because attrition
Table 4.2: Sample Characteristics by Exam
Exam Mean Mean St. Dev. % Female % Married n
Year Age Age
1 1973 37.0 (10.28) 50.0 80.5 3008
2 1981 44.3 (10.05) 50.1 82.9 2921
3 1985 48.3 (9.99) 51.1 83.0 2849
4 1988 51.5 (9.99) 51.5 80.6 2796
5 1992 55.0 (9.83) 52.1 79.9 2709
6 1996 58.6 (9.69) 52.7 77.2 2613
7 1999 61.5 (9.58) 53.1 74.7 2565
Ages in the sample range from 13 in exam 1 to 88 in exam 7.
has been eliminated, the number of individuals at each exam reflects only those that have
survived. Over the health exams, the sample becomes slightly more weighted toward female
and non-married individuals. Table 4.2 also shows the great variability in ages across the
sample. At the first exam, there are individuals who are as old as the average age at the final
exam. Indeed, over the entire sample, ages range from 13 to 88. Finally, because of the small
ethnic minority population in Framingham, Massachusetts, particularly at the onset of the
Original Cohort, for reasons of confidentiality, there is no racial variation in the sample and
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all individuals are white.
Table 4.3 gives sample percentages of the maximum number of years of education by
category. The sample reflects a rather well educated cohort for the time period as nearly 89%
of the sample has a high school degree or better.
Table 4.3: Education
Education % of
Years Sample
0-4 3.2%
5-8 1.0
9-11 6.1
12 32.8
13-16 43.2
17+ 13.8
N = 3008. Percentages reflect
highest attained level of education.
Table 4.4 breaks down the sample by smoking prevalence over exams. Over the seven
exams, the sample smoking prevalence drops from roughly 41% to 11%. Interestingly, at the
first exam, smoking prevelence in the sample is roughly consistent with that of the United
States average prevelence (37% of Americans smoked in 1973).3 However, by the final exam,
the sample percentage of smokers has decreased to roughly 11% whereas the national average
fell to 23.3%. The sample is also clearly older than the general population by the seventh
exam.4
The health markers that I consider are identified by the Framingham Heart Study as those
that are most important in determining an individual’s general 10-year risk for cardiovascular
disease (Wilson et al., 1998; D’Agostino et al., 2008).5 These include systolic and diastolic
blood pressure, total and high-density lipoprotein cholesterol, and diabetes. I do not consider
BMI because, as noted in D’Agostino et al. (2008), total cholesterol is a better risk indicator
3See Chapter 5 for a complete comparison between the Framingham Heart Study participants and the overall
United States prevalence of smoking.
4Centers for Disease Control and Prevention: http://www.cdc.gov/tobacco/basic information/index.htm
5The Framingham Heart Survey: Risk Score Profiles:http://www.framinghamheartstudy.org/risk/index.html
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Table 4.4: Smoking Behavior by Exam
Exam Nonsmokers Light Smokers Heavy Smokers
≤ 1 Pack/Day > 1 Pack/Day
1 59.0% 26.7% 14.3%
2 61.3 24.4 14.2
3 77.2 14.3 8.5
4 81.2 12.8 6.0
5 85.2 11.0 3.9
6 87.9 9.5 2.6
7 88.9 8.7 2.5
when available.6 Table 4.5 provides summary statistics of these variables at each health exam.
Recall that the theoretical model specifies a dichotomous variable for the presence of a
Table 4.5: Health Markers by Exam
Exam Systolic Diastolic High-Density Total Diabetes
Blood Blood Lipoprotein Cholesterol
Pressure Pressure (HDL)
1 122.3 79.0 50.8 197.1 1.8%
(16.1) (10.7) (15.0) (39.4)
2 122.3 78.2 48.6 203.9 2.6
(16.5) (9.8) (13.6) (39.1)
3 123.7 79.0 51.1 212.2 3.5
(16.7) (9.6) (14.8) (41.2)
4 126.8 79.1 49.9 207.5 4.8
(18.8) (10.0) (14.8) (38.5)
5 126.4 74.5 49.9 205.6 6.9
(18.8) (10.1) (15.2) (36.5)
6 128.2 75.3 51.0 206.0 9.6
(18.4) (9.5) (16.0) (37.7)
7 127.2 73.8 53.3 200.6 11.1
(18.7) (9.7) (16.8) (36.6)
Standard deviations are in parenthesis.
chronic condition. The decision to aggregate the data to a dichotomous, chronic condition
or not, level stems from the computation burdens of estimating additional parameters in the
structural model. As in the theoretical model, I assume that upon transiting to a chronic health
6Of course, evidence has shown that body mass index (BMI) and smoking are inversely related. However,
assessing the potential weight gain associated with smoking cessation is beyond the scope of this dissertation.
Furthermore, BMI is a very noisy measure of health, and the Framingham Heart Study 10-year cardiovascular
risk calculator states that, when available, total cholesterol should replace BMI when possible.
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state, an individual remains in that state for life. Table 4.6 shows the percentage of the sample
living with a chronic condition at each health exam. The incidence of new chronic conditions
is in column 3 of table 4.6. I consider an individual to have a chronic condition if any of a
Table 4.6: Chronic Health by Exam
Exam Chronic Condition Newly Chronically Ill
at Exam at Exam
1 0.2% 0.0%
2 4.0 3.8
3 7.0 3.4
4 9.6 3.1
5 12.2 3.9
6 16.0 5.0
7 20.3 4.8
wide variety of cardiovascular diseases and cancers are present. Unfortunately, this definition
does exclude some smoking related chronic conditions such as chronic obstructive pulmonary
disease. This definition is a limitation of the data. The panel nature of the Framingham Heart
Study focuses on heart related conditions and cancers.7 Table 4.7 shows the prevalence of the
five types of heart conditions considered. Myocardial Infarction, or heart attack, makes up
the largest percentage of heart conditions. Various cancers constitute the remaining 28.3% of
the defined chronic conditions. While a large number of cancers are thought to be related to
cigarette smoking, I include all types of cancer as a chronic condition. Finally, because data
Table 4.7: Chronic Health Conditions
Condition Number Percentage
Heart Conditions 1980 71.7%
Myocardial Infarction 559 28.2%
Other Coronary Heart Disease 488 24.6
Cerebrovascular Accident 323 16.3
Intermittent Claudation 182 9.2
Congestive Heart Failure 428 21.6
Cancers 781 28.3%
7See Chapter 10 for a discussion of the limitations of the chronic health definition.
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are available for any chronic conditions that occurred prior to entering the sample, as well
as, the date of a chronic condition after entering the sample, Figure 4.1 shows the cumulative
empirical distribution of individuals in the chronic health state by age. Note that, because the
sample is right censored, and because of death, the data become noisy for ages beyond 75.
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Figure 4.1: Sample Chronic Health Condition Probabilities by Age
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Chapter 5
Empirical Implementation
In estimating the model described in Chapter 3 with the data described in Chapter 4, there
are four hurdles. The first main hurdle lies in the timing of the health exams. While the data
contain only seven exams over a 40-year period, the theoretical model is based on a yearly
decision making process over a finite time horizon. As explained below, I exploit retrospective
questions in the data to construct a dataset that mirrors the timing of the model. This process
generates yearly data for all variables in the theoretical model except health marker data for
years in which no health exam took place. To overcome this problem, I use predictions from
solution to the model to integrate over “off years” as well as to explain the initial condition
for each individual. Given the expanded dataset, the second hurdle is that state variables Ait
and Rit must be constructed from the Framingham Heart Study data in such a way as to
capture an individual’s smoking history and health markers, respectively. For each of these
variables, I employ principal component analysis in a method similar to that of Sickles and
Williams (2008).1 The third hurdle is the identification of the model parameters. As I describe
below, variation in the timing of health exams across individuals helps to identify the model.
Finally, the last hurdle involves modeling permanent unobserved heterogeneity and resolving
the initial conditions problems. This chapter ends with a detailed discussing of my solution
method, likelihood function construction, and maximization routine.
1See Chapter 2 for a discussion of Sickles and Williams (2008).
5.1 Health Exam Timing
While I observe individuals at only seven health exams over a 40-year period, the theoretical
model is based on a yearly decision making process. To reconcile this difference, I proceed
in the following steps. First, in solution to the model, I specify the final period, T , to be
at age 100. That is, the probability of death at the end of period T equals one. The yearly
model is then solved recursively back to age 7, at which point I assume that all individuals
have a smoking stock of zero (i.e. Ai7 = 0, ∀i). This process is described in detail below.
Second, the data from chapter 4 are expanded based upon retrospective questions. With the
exception of the health marker information needed to construct the health marker index, Rit,
data are available to construct a yearly dataset from age seven until an individual either dies
or completes his or her seventh exam. Data in years prior to an individual’s first exam were
constructed based on questions at the first and second exams that asked, if applicable, the
first age at which one started smoking and the age at which one stopped smoking. For later
years in between health exam years, smoking data were imputed based on history and adjacent
health exam data. Specific dates are available in the data for any chronic health and mortality
events.
Figure 5.1 shows the sample probabilities for each smoking choice by age. Because figure
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Figure 5.1: Sample Choice Probabilities by Age
5.1 reports smoking percentages by age, for older ages, the data become noisy because of either
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right-censoring or death. Of the 3008 observations considered, 15%, or 464 individuals, leave
the sample through death.
Table 5.1 presents age and gender specific smoking rates by year from the Framingham
Heart Study and the United States national averages for white Americans.2 As my sample of
individuals ages, certain age groups drop out of the sample; however, almost the entire sample
is present in 1974 and 1985. Interestingly, while generally both men and women in my sample
are consistently below the United States smoking averages, Framingham Heart Study women
tend to smoke more in 1965 and 1974 than average. Furthermore, following some age cohorts
Table 5.1: Framingham Heart Study and United States Smoking Prevalence by Age and Year
1965 1974 1985 1995
FHS U.S. FHS U.S. FHS U.S. FHS U.S.
White Males, Age
18-24 53.2% 53.0 39.3 40.8 - 28.4 - 28.4
25-34 58.9 60.1 43.4 49.5 29.0 37.3 - 29.9
35-44 54.2 57.3 37.9 50.1 29.9 36.6 15.0 31.2
45-64 53.2 51.3 37.2 41.2 22.7 32.1 13.9 26.3
65+ - 27.7 - 24.3 16.9 18.9 6.1 14.1
N 1487 1496 1345 1086
White Females, Age
18-24 50.0 38.4 40.0 34.0 - 31.8 - 24.9
25-34 50.3 43.4 41.2 38.6 22.5 32.0 - 27.3
35-44 42.5 43.9 35.6 39.3 27.0 31.0 17.2 27.0
45-64 45.3 32.7 35.8 33.0 22.5 29.7 14.1 24.3
65+ - 9.8 - 12.3 23.0 13.3 9.7 11.7
N 1496 1502 1364 1206
over time shows that, while Framingham Heart Study men aged 18-24 in 1965 appear to quit
smoking faster than the national average, Framingham Heart Study women aged 18-24 in 1965
smoke more in 1965 and 1974 than the nation average, but then appear to quit more rapidly
in 1985 and 1995.3 Table 5.1 puts the Framingham Heart Study participants in the context
of the United States averages. Initially, individuals in my sample, corrected for age, race, and
2Data are from http://www.cdc.gov/nchs/hus/contents2010.htm#table058.
3To make these comparisons, examine the prevalence of smoking for 18-24 years olds in 1965 by comparing
the difference between Framingham Heart Study individuals and United States averages. Next, because these
individuals are all between 25-34 years old in 1974, compare these averages.
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gender, look similar in terms of smoking prevalence to the rest of the United States. However,
by 1995, a smaller percentage of my sample smokes than average.
Table 5.2 shows general smoking summary statistics from the expanded data. On average,
if an individual ever smokes, he/she starts just before age 20, although the median age is
18. Table 5.3 reports smoking behavior transitions around health exams and chronic health
Table 5.2: Smoking Summary Statistics
Mean (Median) S.D. Min Max
First Age Smoking 19.57 (18) 7.45 7 67
(Conditional on Ever Smoking)
Total Years Smoking 24.78 (24) 14.07 1 68
(Conditional on Ever Smoking)
Tenure Smoking (Years) 21.13 (19) 14.85 1 68
(Conditional on Ever Smoking)
Last Age Smoking 44.76 (45) 12.84 13 76
(Conditional on Ever Smoking and Quitting)
shocks, as well as the overall average transitions. Conditional upon an individual’s smoking
behavior one period prior to each event, the table reports percentages in each smoking option
one and three years after the event. For example, of those individuals smoking heavily one
Table 5.3: Observed Transitions
Behavior One Period Post Behavior Three Periods Post
Behavior One Not Light Heavy Not Light Heavy
Period Prior Smoking Smoking Smoking Smoking Smoking Smoking
Overall Transitions
Not Smoking 95.86% 2.93% 1.22% 91.72% 5.76% 2.51%
Light Smoking 9.21 89.29 1.51 17.35 79.81 2.84
Heavy Smoking 5.66 2.78 91.56 11.12 5.31 83.58
Transitions Around Health Exams
Not Smoking 96.38 3.20 0.42 97.00 2.55 0.45
Light Smoking 21.40 70.29 8.30 29.45 63.50 7.06
Heavy Smoking 14.50 16.47 69.03 20.62 16.48 62.90
Transitions Around Chronic Health Shocks
Not Smoking 98.94 0.89 0.18 97.18 2.59 0.24
Light Smoking 24.78 73.45 1.77 39.36 54.26 6.38
Heavy Smoking 21.43 8.33 70.24 39.71 13.24 47.06
period prior to a chronic health shock, 70.24% continued to smoke heavily one period after
the shock and 47.06% were still smoking heavily three periods after the shock. In both event
cases, more individuals had quit smoking three years post as compared to one year post, but
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considerably more had quit three years after an event than the baseline set of transitions. The
table provides at least antidotal evidence that each event (health exams and chronic health
shocks) alters smoking behavior in the sense that the magnitudes of the transitions, both
one and three years post, are larger than the overall transitions. I compare these descriptive
statistics with predictions from the model in chapter 7.
5.2 Continuous State Variable Construction
For the model to both remain computationally tractable and be consistent with the assump-
tion of conjugate distributions, I need continuous, scalar representations of both an individual’s
smoking history and her health markers. My solution is to employ principal component anal-
ysis (PCA) in the construction of each variable. PCA is a nonparametric technique that
summarizes the total variation in a set of variables into an ordered set of continuous, scalar
principal components. The first principal component is constructed as a linear combination
of data and of factor loadings from the highest eigenvalue eigenvector from an eigenvector
decomposition of the variables’ correlation matrix.4 The trade-off with PCA is both com-
pleteness and interpretation. Only considering the first principal component implies that any
remaining variation in the data (i.e. the second, third, fourth, etc. principal components) is
lost. Furthermore, because the weights used to construct the index are derived only from the
correlation between the variables themselves, the relative magnitudes of the weights may come
into question when predicting an outcome of interest (e.g., mortality). In the context of most
structural models, however, reducing the dimension of the data is clearly adventageous. I will
discuss these issues for both the smoking stock and health marker index construction, as well
as alternative specifications, below.
In constructing Rit, the health marker index, I use PCA with the following (standard-
ized) variables: systolic blood pressure, diastolic blood pressure, total cholesterol, high-density
4For example, given a set of k variables, employing PCA will yield k principal components. If, however,
the first two principal components account for 70% of the total variation in the k variables, and k > 2, the
researcher may find it adventagous to only use the first two principal components as data.
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lipoprotein (HDL) cholesterol, and a diabetes dummy.5 As noted in Chapter 4 and Table 4.5,
these health markers are identified by the Framingham Heart Study as significant predictors
for an individual’s general 10-year risk of cardiovascular disease.6 The first principal compo-
nent of these variables explains approximately 33% of the total variation. Unfortunately, this
implies that two-thirds of the variation in health markers is being lost. However, I now have
a continuous index of health markers. I see two main justifications for using the first princi-
pal component as my measure for the health markers. First, the theory places no restriction
on the amount of information that Rit must convey, only that it conveys some information.
Any computationally tractable definition of Rit will have to be an approximation. That I can
explain a third of the variation in the variables that the medical literature view as signficant
will at least inform to some degree. Second, most papers that use PCA use first principal
components that explain between 20%− 40% of the total variation.7
To provide intuition as to the weights used to create the health index, Table 5.4 presents
results from an OLS regression of the health index on the above health markers. The regression
is run without a constant. Point estimates correspond to the eigenvector values from the first
principal component for the corresponding variables. In this context, the continuous health
index can be interpreted as a measure of bad health (i.e. higher values of the index imply worse
overall health). Note in Table 5.4 that only HDL, or “good” cholesterol, negatively affects the
health index.
As discussed above, the smoking stock summarizes all past smoking decisions prior to
period t. Again using PCA, I define the index Ait as the first principal component of the
following four standardized variables: total number of years smoking at time t (experience),
5PCA is most effective when there exists significant correlation between the variables. As one might expect,
the correlation between these health markers is high.
6While influential in predicting cardiovascular disease, there is no evidence that suggests that these health
markers predict different forms of cancer. In the context of the model, a summary of these health markers will
have less predictive power on the chronic health state if that state is defined as an aggregation of cardiovascular
disease and cancer. However, these markers still provide an overall assessment of an individual’s health. The
extent to which these markers may influence smoking behavior through the Bayesian updating process is an
empirical question.
7In the context of socioeconomic indices, see Vyas and Kumaranayake (2006) for a good overview of PCA.
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Table 5.4: Health Index Regression
Variable Coefficient (Std. Err.)
Systolic Blood Pressure 0.657 ∗∗∗ (0.000)
Diastolic Blood Pressure 0.637 ∗∗∗ (0.000)
Total Cholesterol 0.306 ∗∗∗ (0.000)
High-Density Lipoprotein (HDL) -0.177 ∗∗∗ (0.000)
Diabetes 0.193 ∗∗∗ (0.000)
Significance Levels: ∗∗∗1% Level, ∗∗5% Level, ∗10% Level
number of years smoking at time t since last year not smoking (tenure), number of years at
time t not smoking since last year smoking (cessation), and the intensity of smoking in the
previous period, t − 1.8 I term these variables experience, duration, cessation, and intensity
respectively. Table 5.5 gives sample averages by exam of the number of years of duration,
tenure and cessation. The first principal component explains nearly 52% of the total variation
Table 5.5: Smoking History by Exam
Exam Experience Duration Cessation
1 10.6 7.3 1.9
2 13.0 7.9 4.1
3 14.1 7.6 4.8
4 14.7 6.2 6.1
5 15.1 5.3 7.9
6 15.1 4.4 9.8
7 15.3 3.8 11.3
Values are in years.
in these four variables.
To aid in interpretation of both the resulting smoking stock and the associated parameters
to be estimated, I normalize the smoking stock as follows. First, I run PCA on just those with
some smoking history. That is, individuals with any observed or reported past smoking in each
period are included in the PCA. For example, if an individual takes her first exam at age 18
and begins smoking at age 22, all observations from this individual after age 22 are included
in the PCA, whereas observations prior to 22 are not included. Second, I shift the distribution
of the resulting index such that the person with the lowest value has a stock approximately
8Intensity is measured as the average number of cigarettes per day. Each of these smoking variables is
measured as the value entering the examination.
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equal to zero. Finally, for individuals with no smoking history, I assign a stock value of zero.
Table 5.6 reports the results of a regression of the smoking stock index on the four variables
of interest (excluding a constant). Point estimates correspond to the eigenvector values from
the first principal component for the corresponding variables.
Table 5.6: Smoking Stock Regression
Variable Coefficient (Std. Err.)
Experience 0.309∗∗∗ (0.000)
Duration 0.589∗∗∗ (0.000)
Cessation -0.517∗∗∗ (0.000)
Intensity 0.540∗∗∗ (0.000)
Significance Levels: ∗∗∗1% Level, ∗∗5% Level, ∗10% Level
Notice that while experience, duration, and smoking intensity of an individual all increase the
stock index, cessation from smoking decreases the stock through the depreciation parameter,
δ1. I therefore interpret higher values of the index as more accumulated smoking stock capital.
5.3 Identification
As is discussed below, the parameters of the model are estimated via simulated maximum
likelihood. Generally, the structural model is identified from the variation in the timing of
the health exams. While the number of years between health exams does not directly affect
health9, observationally equivalent individuals with different time gaps between exams may
select different smoking patterns. The different smoking patterns may arise because different
time gaps will induce variation in the belief distribution across individuals. For example, if,
after completing their second health exam at the same time, one individual receives her next
exam in three years while another individual receives her next exam in five years, the data
may show different smoking patterns during the two years in which the first individual had a
different set of beliefs. Table 5.7 shows variation in the number of years between exams (the
vertical tab) for each exam (the horizontal tab). While the gap between the first and second
9The considerable time lag between exams is because the Framingham Heart Study administers health exams
in time “windows”. However, there is no evidence to suggest that those with worse health markers select into
smaller time gaps between exams.
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Table 5.7: Variation in Exam Timing
Years Exam
Between Exams 2 3 4 5 6 7
1 0 0 4 0 0 103
2 0 27 63 36 49 718
3 0 141 1659 358 326 958
4 0 1951 1000 2242 2019 682
5 6 657 57 55 184 90
6 27 65 12 16 28 13
7 1500 8 1 2 7 1
8 1302 0 0 0 0 0
9 64 0 0 0 0 0
10 22 0 0 0 0 0
Total 2921 2849 2796 2709 2613 2565
exam is clearly the longest, and the time gap shrinks at later exams, each exam exhibits
considerable variation across individuals in the number of years to be administered. The
following set of parameters are to be estimated.
Utility Parameters: ΘU = {α0h, . . . , α11h}1h=0
Health Transition Parameters: ΘH = {λ0, . . . , λ10}
Death Transition Parameters: ΘM = {ω0, . . . , ω12}
Smoking Stock Parameters: ΘA = {δ1, δ2, δ3, ση}
Learning and Risk Parameters: ΘR =
{
θ, σθ, σν , φ, ζ
}
Factor Loadings: Θρ =
{{{
ρUhd
}1
h=0
}2
d=0
, ρH , ρM , ρR, ρA
}
Additionally, I estimate the probability weights of the mass points for the discretized distri-
bution of the permanent unobserved heterogeneity, µ. Let Θ = {ΘU ,ΘH ,ΘM ,ΘA,ΘR,Θρ}.
In order to identify the preference parameters, I normalize the utility of death to be zero.
Relative to this normalization, identification of the preference parameters comes mainly from
variation in smoking behavior and health and death transitions over time. For example, dif-
ferent smoking choices across the smoking stock, health marker index, and age levels identifies
the interaction preference parameters. Furthermore, the withdrawal parameter, α9·, is identi-
fied off of variation in the choices of individuals after a period in which an individual quits.
48
Thus, conditional upon having smoked in the previous period, both the reinforcement, α2· and
α6·, and withdrawal effects, α9·, encourage current period smoking. However, withdrawal is
separately identified from the reinforcement effects because, while the smoking stock variable
depreciates at rate δ1 following cessation, the utility cost paid from withdrawal only lasts one
period. Finally, the direct impacts of the stock on utility, α10· and α11·, reflect tolerance in
smoking and are identified by individuals that progress from light to heavy smoking.
In the absence of subjective expectation data, the structure of the model is needed to
identify the presence of learning. Mira (2007) notes that learning can no more be identified
than can rational behavior in the sense that, the model assumes that behavior (learning) fol-
lows from the defined structure. If, however, the prior distribution of beliefs is proved to be
degenerate (i.e., if the null hypothesis that σθ = 0 is not rejected), then the results would
suggest an absence of learning. The identification strategy of the specific learning parameters
is therefore quite subtle. While identification of θ comes from variation in the smoking stock
and health marker index, variation in smoking by individuals over time identifies σθ (Crawford
and Shum, 2005). If, indeed, individuals are learning over time, choices at the end of the time
frame relative to the beginning should better reflect an individual’s true match value, θi. An
additional source of variation that helps to identify the learning parameters is the variation
across individuals in the timing of health exams. There exists considerable variation in the
number of years between exams across individuals; thus, two similar individuals that receive
health information at different frequencies may develop different smoking patterns. Because
of the assumption of conjugate normal distributions, identifying the mean and variance of θi,
in addition to the variance of ν, which is identified from the health marker index transition
equation, is sufficient to characterize the learning process. Finally, the identification of chronic
health and death transition parameters comes from variation in the state variables and the
observed incidence of chronic health and death.
49
5.4 Permanent Unobserved Heterogeneity and Initial Conditions
Permanent unobserved heterogeneity enters the model in a linear fashion through the µ term
and the associated factor loadings. The factor loadings allow for a different effect of the un-
observed µ term everywhere it enters. Rather than placing a distributional assumption on the
underlying unobserved heterogeneity, I approximate its distribution with a step function and
estimate the factor loadings and mass point probabilities with other parameters in the model
(Heckman and Singer, 1984). This discrete factor method has been shown to approximate
both Gaussian and non-Gaussian distributions well (Mroz, 1999).
I first observe individuals at various points in their life cycle (i.e., different ages at the first
health exam) and with a variety of health histories. Failing to properly model these histories
would lead to an initial conditions problem. Furthermore, the initial conditions problem may
lead to an issue of dynamic selection into smoking behaviors. That is, individuals in some
permanently lower (unobserved) health state may select into smoking. However, solution to
the model generates individual probabilities of choice behavior and health/death transitions
for all ages beginning at age seven. Recall that data exist for all smoking, chronic health, and
death events from age seven until either death or the final health exam (exam 7 in the data).
At age seven, I assume that each individual has a smoking stock of zero and has no chronic
health problems. The only remaining initial condition is the initial health marker index upon
entering the sample. Using the model, I can simulate a health marker index for each period
from age seven until the first observed health exam. Hence, I use the model to generate prob-
abilities of an individual’s health history when they are first observed in the sample (Khwaja,
2010). Individuals enter the sample aged between 13 and 62 years. At age seven, I assume that
the lagged value of the health marker index is in the 90th percentile (e.g., good health) of each
health marker that is used to construct the index. I then use the weights from the principle
component analysis to construct the lagged value. Recall that the simulated health marker
index is scaled by demographic characteristics, Xit, as well as the unobserved heterogeneity,
µ, term and its factor loading. Furthermore, individual variation in the data at the first exam
(the initial condition) helps to identify parameters of the model.
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5.5 Solution
The computational hurdle in calculating the conditional choice probabilities in equation 3.9 is
to solve for the integrated Bellman (EMAX) equation in equation 3.8. Technically, the EMAX
equation must be solved for all possible points s in the state space Sit. However, given the
long time frame of the model and the mixed discrete/continuous nature of the state space,
I employ a variant of the Keane and Wolpin (1994) value function interpolation method for
approximating the value function. This method amounts to drawing from the state space,
calculating the resulting EMAX function for each draw, and interpolating the EMAX function
for all other points. The end goal of this procedure is to generate choice probabilities for each
individual i, in each time period t, conditional on the unobserved heterogeneity µ and a trial
set of the parameters, to enter the likelihood function. My iterative solution method proceeds
in two main steps: model simulation and individual specific solution. While the first solution
step yields value function regression coefficients from the simulated model, the second step uses
these coefficients to calculate the conditional choice probabilities, health marker and smoking
stock densities, and chronic health and mortality transition probabilities.
The first step of the solution method is to solve the model for a group of simulated in-
dividuals. The goal of this step is to generate a set of regression coefficients that map from
the state space to the value function. Because the time horizon is finite (T = 100), I can
solve the model using backwards induction and I avoid iterating on the value function itself.
Starting in the final period T , I draw n state vectors and sequences of past smoking behavior
DiT−1 = {di1, . . . , diT−1}.10 Each of these n draws represents one simulated individual. For
each of the n draws, I construct the main equations of the model for period T . Note that
because the probability of death at the end of period T equals one, each of the choice spe-
cific value functions in period T simply equals the current period utility from the smoking
alternative. Next, I posit a relationship between the n calculated value functions and a set
of regressors. The regressors include the drawn state variables in addition to interaction and
higher-order terms. I then run the regression and generate coefficients that are specific to time
10In practice I set n = 100.
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period T . Next, I repeat the above steps for period T−1. When calculating the expected value
function in period T − 1, I use the regression coefficients from period T to approximate the
expected future value function. I repeat the above process for all periods back to age seven,
t = 7; that is, I solve the model for all ages between 7 and 100.
The first stage process is conditional on three factors. First, I conduct the simulation above
for each possible age at which an individual may have taken her first health exam.11 Second, I
discretized the support of the unobserved heterogeneity distribution into K points.12 For each
point k of µ, in addition to each age at the initial health exam, I conduct the above simulation.
Thus, I have a full set of value function regression coefficients (from age 7 to 100) for each age
at initial health exam and for each unobserved type, µ. Finally, the value function regression
coefficients are also conditional on the trial set of parameters used to solve the model.
The second main step, conditional on the same trial set of parameters and using the above
regression coefficients, involves solving the model for each individual. For each individual, I
solve the model backwards from age 100 to generate conditional choice probabilities, health
marker and smoking stock densities, and chronic health and mortality transition probabilities.
This process is complicated by the fact that I only have data for the health marker index in
some periods.
In each period in which individual i undergoes a health exam, he/she must forecast the
future evolution of the state variables and the resulting values associated with all current and
future smoking decisions. Luckily however, because the value function regression coefficients
approximate the next period value function, I must only construct the expected value of the
next period state variables conditional on the current period smoking decision. Because the
chronic health and mortality logit probabilities have closed-form expressions, assuming ratio-
nal expectations makes the next period chronic health and mortality transition expectations
11In the data, the ages range from 13 to 62. As noted above, there exists great variation in the data in the
timing of the health exams. However, in the simulation, regardless of age at the initial health exam, I use the
average number of years between exams to avoid having to simulate the model for all possible combinations of
exam sequences.
12In practice I set K = 3.
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straightforward. To forecast the smoking stock and health marker index values one period for-
ward, I use a Monte Carlo method. Conditional on each draw of the Monte Carlo simulator,
I construct all other probabilities in the model. The average of these probabilities then enters
the likelihood function.
For time periods in which no health exam was taken, in addition to integrating over the
future values of the smoking stock and health marker index, I must also integrate over the
current period value of the health marker index. In this case, I use the exact same method as
integrating over the future health marker index, only using different draws (from those used to
integrate over the future term) of the i.i.d. error term ν. All other probabilities in the model
are constructed conditional on the drawn value of the current period health marker index and
averaged. For a more formal explanation of this method, I now present the construction of the
simulated likelihood function.
5.6 Likelihood Function
Consider first the contribution of individual i to the likelihood function. Given that ηit ∼
N (0, σ2η) and νit ∼ N (0, σ2ν), I can express the probability density functions of Ait and Rit
respectively as:13
Λt = f(ηit|Ait−1, dit−1, µ, ρA,ΘA) = 1
ση
φ
(
[logAit − δ1logAit−1 − δ2dt−1 − ρAµ]/ση
)
(5.1)
and
Ωt = g(νit|Xit, κit, µ, ρR,ΘR) = 1
σν
φ
(
[Rit − ζRit−1 −Xitφ− κit − ρRµ]/σν
)
(5.2)
where φ(·) is the standard normal distribution. Recall, however, that the health marker index,
Rit, and only the health marker index, is unobserved in periods in which a health exam was
13Note that the i subscript has been dropped from the permanent unobserved component, µ. As is shown
below, in the empirical model, the distribution of µ has been discretized to K points of support and is integrated
out of the likelihood function.
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not taken.14 I must, therefore, integrate over Rit in all periods with no health exam. For ease
of exposition, define the dummy y as follows:
yit =
 1 if An exam was taken in year t0 if No exam was taken in t

Define Zy=1it |µ as individual i′s likelihood contribution in period t when yit = 1 and conditional
on unobserved heterogeneity term µ:
Zy=1it |µ =
2∏
d=0
(
p(dit = d|sit, µ)∗Λt∗Ωt∗
1∏
h=0
(
pidht+1|µ
)1[Hit+1=h]∗ 1∏
m=0
(
ςdmt+1|µ
)1[Mit+1=m])1[dit=d]
. (5.3)
Here, piht+1 represents the probability of transiting to health state h in period t+ 1 and ς
m
t+1 is
the probability of transiting to death state m in period t+ 1. Unless a health exam was taken
in the period directly before t, the lagged value of the health marker index in equation 13 is
unobserved. In practice, I use the expected health marker index given the model parameters
as the lagged value. In periods in which yit = 0, define the expected health marker index,
conditional on the model parameters as:
R˜it = Eν(Rit|ΘR, Sit, µ) (5.4)
Here, the expectation operator is taken over the i.i.d. noise term, ν. Other probabilities in the
model are conditional on R˜it for years in which yit = 0.
15 In the period directly after a health
exam, the lagged value of the health marker index (i.e., from the exam and not the simulated
term) is used in the construction of R˜it. Therefore, define Z
y=0
it |µ as individual i′s likelihood
14All right-hand side terms in the health marker equation are observed in these “off” years due to retrospective
questions and/or imputation with the exception of the lagged value of the health marker index when the previous
period did not contain a health exam.
15In practice, I numerically integrate over νit. For each draw of νit, all other probabilities in the model are
constructed. The resulting probabilities are then averaged over the draws.
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contribution in period t when yit = 0:
2∏
d=0
(
p(dit = d|sit, R˜it, µ) ∗ Λt|R˜it ∗
1∏
h=0
(
pidht+1|R˜it, µ
)1[Hit+1=h] ∗ 1∏
m=0
(
ςdmt+1|R˜it, µ
)1[Mit+1=m])1[dit=d]
.
(5.5)
The total conditional (on µ) likelihood contribution from individual i for all time periods
7, . . . , Ti, where Ti is either the period of an individual’s death or their final exam, is:
Li(Θ|µ) =
Ti∏
t=7
[ 1∏
y=0
(
Zyit|µ
)1[Yit=y]]
. (5.6)
Because of the discretized distribution of the unobserved heterogeneity, each individual’s un-
conditional contribution will be a finite mixture of likelihoods. Given K points of support in
the estimated distribution of µ, the unconditional likelihood function contribution for individ-
ual i is:
Li(Θ) =
K∑
k=1
ξkLi(Θ|µk). (5.7)
Where ξk is the estimated probability weight placed on mass point k. The full sample log-
likelihood function is:
L(Θ) =
[ N∑
i=1
logLi(Θ)
]
. (5.8)
The parameter estimates in Θ are estimated via a nested solution method (Rust, 1987). The
inner algorithm solves the dynamic model for each individual conditional on a given set of
parameters and for all mass points of the unobserved heterogeneity distribution. Using the
resulting probabilities, the outer algorithm calculates the unconditional likelihood function,
L(Θ), and attempts to improve the likelihood value via a BHHH gradient method. The
BHHH method is standard in estimating dynamic structural models because, as opposed to
traditional gradient methods such as Newton-Raphson that explicitly construct the Hessian
matrix of the likelihood function. BHHH approximates the Hessian by exploiting the fact that
the likelihood function (L(Θ)) is the sum of individual log-likelihood contributions. Calculating
the second derivatives of the likelihood function would be computationally infeasible for nearly
all dynamic structural models. At the parameters that maximize the log-likelihood function,
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however, the average outer-product over individuals is the covariance matrix of the scores of
the sample. Furthermore, at the true parameters, the covariance matrix of the scores is equal
to minus the expected Hessian matrix (Train, 2009). The total process continues, updating
parameters at each iteration, until the likelihood function is maximized. I assume convergence
at the maximum of the likelihood function when the percentage change of the likelihood value
over an iteration is at or below 0.000001. The model is solved and estimated using MPI parallel
processing techniques for Fortran 90 code.
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Chapter 6
Results
6.1 Parameter Estimates
Table 6.1 reports the main parameter results. The estimated utility constants, α00 and α01,
for the absence of a chronic health condition and a chronic health condition respectively, are
quite intuitive given that the utility of death has been normalized to zero. The total marginal
utility of current period light and heavy smoking is a function of α1· . . . α8·. A key component
of rational addiction theory, indeed the defining feature of an addictive good under rational
addiction, is that past consumption reinforces current consumption. That is, the marginal
utility of smoking is increasing in the smoking stock. My results are consistent with this
adjacent complementarity defined in Becker and Murphy (1988). In the absence of a chronic
illness, both light and heavy smoking are found to be reinforcing (i.e., α20, α60>0). Indeed, I
find that heavy smoking is much more “reinforcing” than light smoking. My results also suggest
that the marginal utility of light smoking in the absence of a chronic condition is invariant
to the health marker index but increasing in age. Interestingly, the marginal utility of heavy
smoking is decreasing in the health marker index and invariant to age when free of a chronic
condition; however, when chronically ill, the marginal utility of heavy smoking is increasing
in the health markers (α71 = 0.001) and decreasing in age. Withdrawal from smoking, (i.e.,
smoking in period t − 1 and not smoking in period t) is negative for all health states and
larger in magnitude when free of a chronic illness. The withdrawal effect, in addition to the
strong reinforcement effect, both drive smokers to continue smoking. Finally, the tolerance
effect (α10·) flips sign across health states. In the absence of a chronic condition, smoking is
found to have a tolerating effect (i.e., lower utility from a larger smoking history).
Several interesting trends emerge from these results. First, note that baseline marginal
utility of both light and heavy consumption is negative with the exception of heavy smoking
with a chronic condition. This finding is driven by the absence of an outside consumption good.
Here, the only tradeoff from current smoking is the potential for future health consequences.
As suggested by the rational addiction literature, the model cannot explain why individuals
start smoking. The estimated preference parameters in the absence of a chronic illness suggest
that, for a never smoker under the age of 25, an exogenous shock preference shock is required
to get an individual to start smoking. That is, for the never smoker, the model predicts that
smoking is unappealing. In addition to the negative marginal utility in the absence of a past
smoking history, the dynamic considerations of the model suggest that smoking will increase
the probability of future chronic illness and death through the smoking stock, which increases
future smoking probabilities through the positive reinforcement effect, as well as, increasing
the health marker index.
The second main trend from the estimated preference parameters is the reversal in sign
of several preference parameters upon succumbing to a chronic illness. The baseline marginal
utility of heavy smoking when in the chronic health state (α51) flips to positive. Along with
the positive reinforcement (α21, α61 > 0) and the flip in the sign of the effect of the stock on
utility (α101 > 0), individuals now face a positive marginal utility from heavy smoking.
The model finds evidence of a small degree of individual variation in the effect of the
smoking stock (Ait) on the health marker index (Rit) as the estimated standard deviation of
θ, σθ, is nonzero. Recall further that the null hypothesis of σθ equaling zero is my explicit test
for the presence of learning. While the results do suggest the presence of learning, the signals
received at each health exam are quite noisy. The estimated standard deviation of the random
error term (σν) is large relative to θ and σθ.
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Table 6.1: Main Parameter Estimates
Description Chronic Condition Parameter Estimate ASE
Utility Parameters
Constants
No α00 25.947 1.808
Yes α01 1.364 0.272
Consumption - Light Smoking
Constant No α10 -6.128 0.117
Consumption*Smoking Stock No α20 0.001 0.000
Consumption*Health Marker Index No α30 0.000 0.000
Consumption*Age No α40 0.070 0.001
Consumption Yes α11 -7.479 0.194
Consumption*Smoking Stock Yes α21 2.479 0.018
Consumption*Health Marker Index Yes α31 -0.005 0.001
Consumption*Age Yes α41 0.002 0.001
Consumption - Heavy Smoking
Constant No α50 -18.753 0.043
Consumption*Smoking Stock No α60 1.704 0.010
Consumption*Health Marker Index No α70 -0.001 0.000
Consumption*Age No α80 0.000 0.000
Consumption Yes α51 0.015 0.004
Consumption*Smoking Stock Yes α61 2.483 0.018
Consumption*Health Marker Index Yes α71 0.001 0.000
Consumption*Age Yes α81 -0.068 0.004
Withdrawal
No α90 -6.927 0.046
Yes α91 -1.539 0.133
Smoking Stock
No α100 -0.025 0.007
Yes α101 2.636 0.051
Smoking Stock Squared
No α110 -0.002 0.001
Yes α111 -0.596 0.005
Learning Parameters
Mean Effect θ 0.003 0.000
Standard Deviation of θi σθ 0.098 0.004
Standard Deviation of ν σν 1.024 0.004
Additional Health Marker Index Parameters
Lagged Health Marker Index ζ 0.807 0.001
Age in Years φ1 0.005 0.000
Female φ2 -0.122 0.003
Education in Years φ3 -0.011 0.001
Married φ4 0.000 0.000
Constant φ5 1.039 0.013
Table 6.2 provides estimates of all other estimated model parameters. These estimates
are not marginal effects and therefore are difficult to interpret because each outcome (health
marker index, chronic health, death, etc.) is a complex function of entering period states and
per-period decisions. In the simulation section below, I describe the results of simulations
that isolate the effects of each variable on the system. However, a casual interpretation of
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the results in Table 6.2 does yield some interesting insights. The parameter estimates of the
smoking stock evolution equation indicate that an individual’s stock of smoking depreciates
faster than suggested by the medical literature. δ1 suggests that, given cessation from smoking
over the cycle of one year, the smoking stock is reduced by approximately 57%.1 In the context
of the model, 57% depreciation implies that after about six years of smoking cessation, an
individual may have roughly the same health marker index and chronic health and death
tranistion probabilities as a lifelong nonsmoker, all else equal. Additionally, the estimated
magnitude of investment return in the smoking stock is greater for heavy compared to light
smoking (δ2 < δ3).
As noted above, the estimated mean effect of the smoking stock on the health markers is
positive (θ = 0.003). A greater smoking history therefore implies a higher, and thus worse
health marker index. According to Table 6.2, a higher health marker index implies a higher
probability of chronic illness (through the positive sign on λ1), albeit at a decreasing rate
(λ2¡0), and death (through the positive signs on ω1, ω2, ω3, ω5, and ω6. Furthermore, given a
chronic illness, the probability of death is lower during the 1980s (ω7 < 0) and 1990s (ω8 < 0)
both relative to before 1980 to capture exogenous advances in medical technology over time.
1Note that while this suggests a large amount of depreciation, the factor loading on unobserved heterogeneity
for the stock equation slows that depreciation.
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Table 6.2: Other Parameter Estimates
Description Parameter Estimate ASE
Smoking Stock Parameters
Depreciation Rate δ1 0.430 0.002
Investment, Light Smoking δ2 0.335 0.001
Investment, Heavy Smoking δ2 0.411 0.002
Standard Deviation of η ση 0.134 0.000
Chronic Health Parameters
Constant λ0 -12.040 0.057
Health Marker Index λ1 0.207 0.016
Health Marker Index Squared λ2 -0.010 0.001
1980s*Health Marker Index λ3 0.000 0.000
1990s*Health Marker Index λ4 0.000 0.000
Choice λ5 0.336 0.024
Choice*Health Marker Index λ6 -0.008 0.002
Age λ7 0.119 0.001
Education λ8 0.007 0.001
Gender λ9 0.019 0.005
Married λ10 -0.070 0.005
Mortality Parameters
Constant ω0 -8.805 0.104
Health Marker Index ω1 0.001 0.000
Health Marker Index Squared ω2 0.001 0.000
Chronic Health State ω3 4.868 0.094
Choice ω4 0.000 0.000
Choice*Health Marker Index ω5 0.013 0.002
Choice*Chronic Health State ω6 0.503 0.021
1980s* Chronic Health State ω7 -0.086 0.017
1990s* Chronic Health State ω8 -0.214 0.030
Age ω9 0.041 0.002
Gender ω10 -0.061 0.014
Education ω11 -0.135 0.005
Married ω12 -0.204 0.028
Heterogeneity Parameters
Utility: No Chronic Condition
Not Smoking ρu00 0.066 0.018
Light Smoking ρu01 2.664 0.161
Heavy Smoking ρu02 8.619 0.103
Utility: Chronic Condition
Not Smoking ρu10 0.964 0.148
Light Smoking ρu11 -0.081 0.021
Heavy Smoking ρu12 0.132 0.033
Stock ρA 0.647 0.002
Health Marker Index ρR 0.000 0.000
Chronic Health ρH 0.001 0.000
Mortality ρM 1.027 0.122
Mass Points and Probabilities
Mass Point 1 µ1 0.000 -
Mass Point 2 µ2 1.270 0.122
Mass Point 3 µ2 1.000 -
Coef. Weight on Mass Point 1 θ1 -2.622 0.688
Coef. Weight on Mass Point 2 θ2 -1.231 0.204
Miscellaneous Parameters
Discount Factor β 0.950 -
Log-Likelihood Value L(Θ) -30481.266
Mass points 1 and 3 are fixed at 0 and 1 respectively. Mass point 2 is estimated and
its location is
exp(1.270)
1+exp(1.270)
= 0.781. The corresponding probabilities of mass points 1
through 3 are 0.053, 0.214, and 0.733.
The model is estimated with three points of support for the discretized unobserved hetero-
geneity distribution. The combination of positive estimated factor loadings on the marginal
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utility of smoking and on mortality provide evidence of positive selection. That is, those that
are more likely to smoke are also more likely to die independently of smoking. These results
suggest that there are certain permanent factors (e.g., propensity towards a risky lifestyle,
genetics, etc.) that are correlated with both smoking and mortality. Interestingly, these un-
observed factors are relatively uncorrelated with health markers or chronic health outcomes.
However, the unobserved factors may still predict chronic disease induced mortality for higher
type individuals if these factors drive smoking through the positive factor loadings on the
marginal utility of smoking. By smoking more, these individuals build a larger smoking stock,
and consequently are more likely to continue smoking through reinforcement. Because smoking
predicts the onset of chronic illness, the unobserved factors may be indirectly linked to chronic
illness caused mortality. Finally, because the model predicts that individuals only start smok-
ing because of an exogenous shock to , for individuals of type three, smoking initiation may
occur for a “smaller” shock because the positive factor loading on light and heavy smoking
“offsets” some of the negative values for the direct marginal utility of smoking, α1· and α5·.
6.2 Model Fit
Figure 6.1 summarizes the relationship between the model’s predicted probabilities and the
observed data by age. Each pane of the figure represents one specific smoking option. For
each individual, I compare observed smoking decisions and predicted smoking probabilities for
periods up to either her final exam (exam seven) or death. I then average the results across
individuals at each age.2 The model predictions generated from the solution routine fit the
data well even at ages for which there are not many observations.
Table 6.3 reports sample and predicted smoking probabilities by health exam and health
state. I do not include a table on model fit by exam conditional on being in the chronic health
state because less than one, three, and seven percent of individuals have a chronic condition
in exams one, two, and three respectively. Note however that the average predicted choice
probability across all health exams conditional on being in the chronic health state mirrors
2Despite the fact that the model is solved from age 7 to 100, the figure only presents results for ages 20 to
75. Outside of the 20 to 75 age range, there are insufficient data for an informative comparison.
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Figure 6.1: Smoking Behavior by Age: Predicted and Sample Probabilities
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the observed probabilities in the data fairly well. Table 6.3 suggests that the model does a
good job of predicting whether or not an individual smokes at all. The model slightly under
predicts light smoking and slightly over predicts heavy smoking.
Table 6.3: Model Fit: Choice Probabilities
Not Smoking Light Smoking Heavy Smoking
Exam Model Data Model Data Model Data
Unconditional on Hit. # Person/Year Obs.=19,461
1 60.68 59.01 25.68 26.70 13.64 14.30
2 68.74 61.35 19.97 24.44 11.29 14.21
3 71.32 77.22 18.64 14.25 10.03 8.53
4 78.35 81.22 14.50 12.77 7.15 6.01
5 82.53 85.16 12.00 10.96 5.47 3.88
6 86.72 87.87 9.30 9.53 3.98 2.60
7 90.21 88.89 6.82 8.65 2.97 2.46
Mean 76.94 77.25 15.27 15.33 7.79 7.43
Conditional on Hit = 0. # Person/Year Obs.=17,601
1 60.68 58.99 25.71 26.72 13.61 14.29
2 68.91 61.43 20.07 24.24 11.02 14.33
3 71.64 77.31 18.76 14.23 9.60 8.46
4 78.38 80.93 14.77 13.02 6.85 6.05
5 82.47 84.91 12.45 11.10 5.08 3.99
6 86.58 87.42 9.80 9.85 3.61 2.73
7 90.01 88.22 7.25 9.14 2.75 2.64
Mean 76.95 77.03 15.54 15.47 7.50 7.50
Conditional on Hit = 1. # Person/Year Obs.=1,860
Mean 75.69 79.27 11.03 13.64 13.28 7.09
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Figure 6.2 compares the observed sample probabilities of chronic health with the predicted
health probabilities, as generated by the model at the estimated parameter values. As in Figure
6.1, Figure 6.2 averages predicted and sample probabilities across individuals by age only for
those individuals with an observation at that age. Figure 6.2 reflects both transitions to and
surviving members of the chronic health state. This is because solution to the model yields a
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Figure 6.2: Chronic Health State by Age: Predicted and Sample Probabilities
predicted probability of transiting to a chronic health state of one for individuals already in
that state. Note that for most ages, the model slightly over predicts the probability of being
in a chronic health state.
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Chapter 7
Simulation Design
In this chapter, I describe my simulation of smoking behavior and health outcomes using
the structural model and the estimated parameters. Using my simulated sample, I address how
learning from personalized information may impact smoking behaviors and health outcomes,
as well as, how smoking affects morbidity and mortality outcomes. These results are presented
in chapters 8 and 9, respectively. My simulations proceed as follows. First, I construct a simu-
lated sample of 1000 individuals that mirrors the joint distribution of observable demographic
characteristics (education, gender, marriage, and initial age upon entering the Framingham
survey) of the Framingham sample. Next, for each simulated individual i, I construct 50 sets
of match value, unobserved heterogeneity, and error draws over the estimated time frame.
{
θik, µik,
{
νikt, ηikt, {iktd}2d=0
}100
t=7
}50
k=1
.
Smoking behavior and health outcomes are then simulated for each of the 50,000 observations
from age seven until death.
First, I reconstruct Table 5.3 using the simulated smoking behavior to evaluate the model’s
performance in capturing overall smoking transitions and transitions around significant events.
These results are reported in Table 7.1.1 For those simulated to be not smoking in any given
period, one period prior to a health exam, or one period prior to a chronic health shock, the
1Transitions around health exams are unconditional on chronic illness.
simulated smoking probabilities one and three periods after these events mirror those from the
data. The model does less well in simulating behavior conditional on lagged light or heavy
smoking. While the simulated probabilities of not changing behavior after one of the three
events reflect those from the data, the model tends to under predict the probability of quitting
and over predict the probability of switching to a different smoking intensity. However, the
model does capture the general trend that more individuals have quit three years after an
event when compared to one year after.
Table 7.1: Predicted Transitions
Behavior One Period Post Behavior Three Periods Post
Behavior One Not Light Heavy Not Light Heavy
Period Prior Smoking Smoking Smoking Smoking Smoking Smoking
Overall Transitions
Not Smoking 97.80% 2.07% 0.09% 95.89% 3.30% 0.68%
Light Smoking 18.65 53.56 27.77 26.49 42.68 30.79
Heavy Smoking 3.62 31.62 64.74 7.73 35.05 57.18
Transitions Around Health Exams
Not Smoking 98.73% 1.22% 0.05% 97.75% 1.98% 0.27%
Light Smoking 11.76 63.81 24.43 21.75 54.01 24.24
Heavy Smoking 4.66 37.90 57.44 9.91 42.49 47.60
Transitions Around Chronic Health Shocks
Not Smoking 99.16 0.50 0.34 98.92 0.65 0.43
Light Smoking 32.78 44.09 23.13 55.86 27.55 16.59
Heavy Smoking 11.49 34.65 53.86 24.22 27.97 47.81
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Chapter 8
Assessing the Effect of Information on
Smoking Behavior
In this chapter, I use the simulate the model as described in chapter 7 to evaluate coun-
terfactual scenarios that alter either the timing or the frequency with which information is
received. First, to demonstrate the speed at which individuals learn, Table 8.1 reports the
change in the average posterior variance after each health exam of the baseline simulation.
Note that after the first exam (i.e., the first signal of information) the posterior variance de-
creases by nearly 20%. By the seventh exam, the mean posterior variance has been decreased
by 40%. In spite of the “honing in” on individuals’ true match values, smoking behavior
appears to only slightly be influenced by learning. As a natural benchmark, I compare the
Table 8.1: Posterior Variance by Exam: The Speed of Learning
Exam Mean Posterior Variance % Decrease Cummulative % Decrease
Initial Prior 0.0095 - -
1 0.0076 19.9% 19.9%
2 0.0069 8.7% 26.9%
3 0.0066 4.7% 30.3%
4 0.0064 3.6% 32.8%
5 0.0061 4.0% 35.5%
6 0.0059 3.8% 37.9%
7 0.0057 2.9% 39.7%
predictions of the baseline model to results from specifications with no learning (i.e., σθ = 0),
complete information (i.e., τit = θi ∀t), and a situation where an individual undergoes yearly
health exams as opposed to every four years. Figure 8.1 presents the mean percentage dif-
ference of simulated individuals choosing each smoking option for each information scenario
relative to the baseline prediction. Somewhat counter intuitively, the simulations suggest that
the effect of more information, that is, yearly exams, is only to encourage individuals to smoke
lightly in later life. In the extreme, with complete information, individuals are more likely to
smoke lightly at all ages. In both cases, there is no apparent change in heavy smoking. One
possible explanation for this finding is that, because the effect of the smoking stock on the
health marker index is small (θ = 0.003) and because the estimated standard deviation of the
effect is large relative to the mean, upon learning their true match value, individuals feel that
the health effects of smoking are manageable.1 Ultimately, the effects of different information
regimes are quit small. Even with yearly exams, by age 70, the difference in average smoking
rates relative to the baseline model predictions are only approximately 0.06% higher.
1For match values that are negative, there may be an incentive to continue to smoke because an increased
smoking stock will decrease the health marker index, which in turn, will lower chronic health and death proba-
bilities. Other experiments in which health signals where positively amplified, that is, while the health marker
index evolved according to the estimated structural parameters, individuals received signals that suggested
“scary” results, induced individuals to quit significantly more rapidly than the baseline results.
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Figure 8.1: Average difference in smoking probabilities, relative to baseline choices, by age
and across different policy scenarios
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Chapter 9
Assessing Health Effects and Health
Selection
I use the simulated model to address how smoking impacts the age of chronic health onset
and death. Figure 9.1a reports, by age, the percentage of the simulated sample with a chronic
condition while forcing individuals to 1.) never smoke, 2.) smoke lightly from age 18, and 3.)
smoke heavily from age 18.1 Under these same forced behaviors, Figure 9.1b shows, by age,
the percentage of the simulated sample that remains alive. The results in Figure 9.1 confirm
the findings in Sloan et al. (2003) that the detrimental effects of smoking occur largely after
the age of 50. Indeed, the gap in the percentage of the sample in the chronic health state
between never smokers and heavy smokers widens from less than 10% at age 50 to more than
17% at age 70. Similarly, while the difference in those surviving to age 50 between heavy
and never smokers is five percentage points, that gap widens to 30 percentage points at age
70. These results are roughly inline with those of Doll et al. (2004). Those authors find a
difference of approximately 28 percentage points at age 70 when considering never smokers
and smokers. The first half of Table 9.1 reports the mean age of onset for various health
outcomes. Individuals who are forced to smoke lightly and smoke heavily from age 18 onwards
face a mean age of chronic health onset that are approximately two and four years earlier than
those forced to never smoke. While Doll et al. (2004) report that smoking shortens the lifespan
1Recall from the structural model that I assume that, upon transiting to a chronic health state, an individual
remains in that state for life.
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Figure 9.1: Percentage of simulated sample a.) in the chronic health state and b.) remaining,
by age and quit status
by ten years, my results suggest the reduction is approximately four and eight.2
While Doll et al. (2004) only condition their results on decade of birth and gender, I report
results that are conditional on both observed and unobserved factors. Here, I highlight the
importance of incorporating unobserved heterogeneity. Figure 9.2 plots the same two graphs
as in Figure 9.1 but now conditions each result by unobserved “type”. Panels a. and b.
report health outcomes under the baseline rational choice simulation whereas panels c. and d.
2Doll et al. (2004) do not take into account intensity of smoking in these calculations. My results indicate
that, conditional on smoking, the intensity with which one smokes is an important factor explaining health
outcomes.
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report health outcomes assuming that all simulated individuals never smoke. Note that while
unobserved heterogeneity does not play a significant role in chronic health transitions, the
model predicts that type three individuals face lower expected longevity in both the baseline
and nonsmoking simulations. Recall that the alternative specific factor loadings in the utility
function greatly increase the marginal utility of smoking for individuals of a higher type.
Indeed, the model predicts that only individuals with the largest mass point, type three, will
ever smoke. Therefore, Figure 9.2 demonstrates that, independent of smoking, individuals of
a higher type face lower expected longevity.
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Figure 9.2: a. Simulated chronic health state by age at baseline. b. Simulated longevity by
age at baseline. c. Simulated chronic health state by age assuming no smoking. d. Simulated
longevity by age assuming no smoking.
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Next, I use the model to simulate chronic health and death outcomes under different lifetime
smoking paths to assess the impact of smoking cessation on these outcomes. I simulate health
outcomes assuming that an individual smokes heavily from age 18 and quits forever at ages
30, 40, 50, and 60. The results, reported in Table 9.1, imply that quitting smoking at ages
30, 40, 50, and 60 years of age increases life-expectancy by approximately 8, 7.75, 7, and 5.5
years, respectively. These results suggest clear life expectancy gains from quitting at all stages
of the life cycle.
Table 9.1: Age of Chronic Health Onset and Death
Variable Mean Age of Mean Age of
Chronic Health Onset Death
Never Smokes 70.75 77.60
(10.72) (11.60)
Smokes ≤ 1 Pack/day from Age 18 68.91 73.32
(10.89) (11.19)
Smokes > 1 Pack/day from Age 18 66.79 69.58
(10.87) (10.94)
Smokes > 1 Pack/day from Age 18 and
quits at Age 30 70.77 77.58
(11.00) (11.85)
quits at Age 40 70.54 77.32
(11.33) (12.28)
quits at Age 50 69.98 76.60
(11.83) (11.02)
quits at Age 60 66.55 74.99
(10.91) (13.85)
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Figure 9.3 shows the survival percentages by age for the different smoking patterns. Note
that for individuals that quit at age 30, their expected longevity is roughly identical to never
smokers. Similarly, quitting by age 40 has minimal effects on mortality probabilities. Individ-
uals that smoke into their fifties and sixties, however, have a much more likely chance of dying
prematurely.
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Figure 9.3: Percentage of simulated sample remaining, by age and quit status
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Chapter 10
Conclusion
This study formulates and estimates a dynamic stochastic model of smoking behavior. The
model extends the classic rational addiction model to allow for health learning. By estimating
the structural parameters of the model, I capture preferences and expectations in the tradeoff
between smoking and the potential for future health shocks. The structural approach also
allows for counterfactual simulations that a.) assess the importance of health marker infor-
mation in the decision to smoke cigarettes, and b.) capture the direct effect of smoking, and
smoking cessation, on different health outcomes while controlling for unobserved heterogeneity.
Generally, I find that significant reinforcement and withdrawal effects drive smoking dy-
namics by altering the future marginal utilities of smoking. The reinforcement effect is esti-
mated with a novel construction of past smoking behavior that is consistent with the theoretical
notion of a “smoking stock”. I empirically construct this stock as a weighted average of sev-
eral measures of smoking history using using principal components analysis. Consistent with
the theory, individuals understand that different smoking choices influence the smoking stock
through depreciation and investment coefficients. The smoking stock then reinforces future
smoking, through the marginal utility of smoking, and influences health, through the health
marker index.
Estimates of the structural parameters suggest that there exists heterogeneity in the effect
of the accumulated smoking stock on an index of health markers. Despite this heterogene-
ity, learning about an individual’s own place in the distribution of this effect, at least in the
Framingham Heart Study setting, does not appear to significantly inform smokers about the
long-term health consequences of smoking. In fact, learning about how smoking effects health
markers may actually slightly increase moderate smoking in older individuals. However, indi-
viduals that receive sharp, discrete shocks that imply worse health markers typically do scale
down their smoking behavior (either by quitting or lowering the intensity with which they
smoke). Only when a health marker shock pushes an individual’s health markers into the
worst 10% does the resulting change in beliefs have a significant effect on smoking behavior.
Therefore, my results are consistent with the literature on personalized health information
that have found changes in smoking behavior after serious health shocks (Smith et al., 2001;
Sloan et al., 2003; Khwaja et al., 2006; Arcidiacono et al., 2007).
The lack of a change in smoking to marginal changes in health markers, observed from
Framingham Heart Study health exams, may be evidence of some limitations of this study.
First, while the FHS administers health exams every two to eight years, individuals may be
observing their health markers at other doctor visits. Interim doctor visits may induce indi-
viduals to quit smoking; however, the econometrician would only observe that the individual
quit. With respect to the model, the observed quitting would be attributed to the preference
error, . In this case, the conclusion would not be that health markers are uninformative as
to the implications of smoking, but rather that the Framingham Heart Study signals of infor-
mation do not provide any additional information to what is already known. Because of this
possibility, I interpret my results on as a lower bound on health marker learning.
Second, as noted in Sloan et al. (2003), smoking behavior may be altered by a change
in risk perceptions, which may be changed by new information. Because of the absence of
subjective expectation data regarding the effect of smoking on health markers, I am required
to place more structure on the learning process. Thus, the assumption of conjugate normal
distributions for the signal of information and beliefs may be driving the results. Alterna-
tively, I could specify a beta/binomial learning process. Here, a discrete signal of information
(e.g., blood pressure exceeding some threshold) causes individuals to update their continuous
belief distribution.1 However, learning about multiple health marker discrete shocks would
1Recall that a central goal of this dissertation is to examine the effects of health information prior to major
health events. While a heart attack, say, is clearly a discrete health shock that may greatly alter risk perceptions
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be computationally intractable. Furthermore, it is not clear how one could both define the
relevant signal (i.e., which health marker) and it’s corresponding threshold. I leave different
specifications of the learning process for future work.
I find evidence of positive selection with respect to smoking and mortality by estimating the
correlation in permanent unobserved heterogeneity between these outcomes. Factor loadings
that dictate the effect of the permanent unobserved term on the marginal utility of smoking
and on mortality are both estimated to be positive. This finding suggests that individuals
that are more likely to smoke, are also more likely to die independently of smoking. Inter-
estingly, the factor loadings that capture the correlation in permanent unobservables across
smoking and chronic health and health markers are not statistically different from zero. This
finding suggests that, while there exists an unobserved relationship between the propensity to
smoking and mortality, the excess in mortality cannot be attributed directly to chronic disease
(as defined in this paper) or health markers. However, as noted above, if unobserved factors
drive certain individuals to smoke, and smoking predicts the onset of chronic conditions, the
unobserved factors may still predict disease related mortality through smoking.
Simulations of the structural model confirm the positive selection and suggest that, when
controlling for unobserved heterogeneity, the effects of smoking on mortality outcomes may be
less extreme than previously estimated. I find that smoking heavily from age 18 can reduce life
expectancy by eight years relative to life-long non-smokers and by four years relative to those
smoking only lightly (≤ 1 pack/day) from age 18. I compare my results to those of Taylor
et al. (2002); Doll et al. (2004); Brønnum-Hansen et al. (2007) that find overall longevity loss
from daily smoking to be roughly 7.4-10.5, 10, and 8.7-10.4 years, respectively. Furthermore,
quitting smoking by age 30 implies relatively few chronic health or mortality differences, on
average, from life-long non-smokers; however, waiting to quit until age 60 implies that the
health consequences may be severe. Indeed, as suggested by the literature, the major effects
of smoking on health are realized after age 50 (Sloan et al., 2003). With respect to the
estimated health effects, an important limitation of this dissertation is the definition of a
and smoking behavior, the focus here is on health markers.
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chronic condition. Due to data limitations, the dichotomous variable for chronic health used
throughout does not capture all diseases that are caused by smoking. For example, the Fram-
ingham Heart Study data do not include panel data for chronic obstructive pulmonary disease
(COPD). Given that COPD is the number four leading cause of death in the United States2,
the omission of COPD in the chronic health indicator may understate the importance of both
disease in the probability of death and the extent to which preferences for smoking vary across
chronic health states. Furthermore, I can only assess the correlation in permanent unobserved
factors across smoking, mortality, and cardiovascular and cancer related chronic health.
The two main questions of this dissertation should guide future work. First, are there
sources of information, personalized or otherwise, that effectively convince individuals to stop
smoking that also are not major health shocks? Do health markers influence smoking behav-
ior in settings other than the Framingham Heart Study? It would be interesting to collect
subjective expectation data on risk perceptions in which surveyors explicitly mention individ-
ual specific variation in health markers. Would these data show a role for health markers to
change risk perceptions and subsequent smoking behavior? Second, what are the sources of
unobserved heterogeneity that are shown to be correlated across preferences for smoking and
mortality. Would controlling for and modeling parental smoking behavior or parental health
outcomes significantly change the role of unobserved heterogeneity in the results of this disser-
tation? Furthermore, how would the unobserved heterogeneity distribution change if alcohol
consumption was explicitly modeled? In future work, I hope to answer these questions.
2http://www.nhlbi.nih.gov/health/dci/Diseases/Copd/Copd WhatIs.html
79
Appendix A
Bayesian Updating
Here, I derive the posterior beliefs discussed in the main text (Equations 4 and 5). I assume
rational expectations such that an individual’s initial belief upon entering the sample regarding
their true θi is the population distribution:
E0(θi) = τi0 = θ
V0(θi) = ψi0 = σ
2
θ .
Consider an individual in period t with smoking stock Ait. For ease of exposition, assume that
an individual takes a health exam each period. When deriving the posterior beliefs in period
t, an individual considers only her prior beliefs (τit−1, ψit−1) and her signal of information kit.
According to Bayes’ Rule, the posterior distribution, ft, of θi is given as:
ft(θi|κn, τit−1, ψit−1) ∝ ft−1(θi)g(κit|Ait, θi, σν). (A.1)
Note that while g(κit|Ait, θi, σν) conveys information about κit, an individual knows Ait and,
because θi is time invariant, can therefore infer information about θi over time. This will
become more clear in the interpretation of the posterior mean and variance. First consider
g(κit|Ait, θi, σν):
g(κit|Ait, θi, σν) = 1
(2piσ2ν)
1
2
exp
( 1
2σ2ν
(κit − θiAit)2
)
. (A.2)
Note that because we are concerned with the distribution of θi, any term that does not include
θi can be treated as part of the normalizing constant. We can ignore the first term within the
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parenthesis:
∝ exp
( −1
2σ2ν
(− 2θiκitAit + θ2iA2it)).
Simplifying and completing the square yields:
∝ exp
(
− A
2
it
2σ2ν
(
θi − κitAit
A2it
)2)
.
Notice that the term subtracted from θi is the within (individual i) variation ordinary least
squares estimate of θi from the n
th signal of information. Define θˆit =
κitAit
A2it
. Substituting for
θˆit, we have that:
g(κit|Ait, θi, σν) ∝ exp
(
− A
2
it
2σ2ν
(
θi − θˆit
)2)
. (A.3)
Now consider the prior probability distribution of θi:
ft−1(θi) =
1
(2piψit−1)
1
2
exp
( 1
2ψit−1
(θi − τit−1)2
)
. (A.4)
The nice aspect of the conjugate distribution assumption is that we can characterize the
posterior distribution sufficiently with closed form expressions for the posterior mean and
variance. Therefore, we only have to characterize that part of the posterior density that
captures the mean and variance. In that light, consider the product of the exponential portions
of Equations A.3 and A.4 after rearranging terms and absorbing those without θi into the
normalizing constant:
ft(θi) ∝
(
− 1
2ψit−1σ2ν
(
θ2i
(
A2itψit−1 + σ
2
ν
)− 2θi(A2itψit−1θˆit + σ2ντit−1))). (A.5)
After rearranging and completing the square, we have the kernel of a normal distribution
representing the posterior distribution:
ft(θi) ∝
(
− A
2
itψit−1 + σ
2
ν
2ψit−1σ2ν
(
θi −
(A2itψit−1θˆit + σ2ντit−1
A2itψit−1 + σ2ν
)2))
.
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The posterior mean and variance is:
τit = E(θi|κt, τit−1, ψit−1) =
(
A2itψit−1
A2itψit−1 + σ2ν
)
θˆit +
(
σ2ν
A2itψit−1 + σ2ν
)
τit−1 (A.6)
ψt = V ar(θi|ψit−1, σν) = ψit−1σ
2
ν
A2itψit−1 + σ2ν
. (A.7)
Rearranging these equations yields the posterior mean and variance equations above.
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